<!DOCTYPE html>
 <!--[if lt IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8 lt-ie7"> <![endif]--> <!--[if IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8"> <![endif]--> <!--[if IE 8]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9"> <![endif]--> <!--[if gt IE 8]><!--> <html class="aui ltr" dir="ltr" lang="en-US" prefix="og: http://ogp.me/ns#"> <!--<![endif]--> <head> <title>Feverfew for preventing migraine - Wider, B - 2015 | Cochrane Library</title> <meta content="Feverfew for preventing migraine - Wider, B - 2015 | Cochrane Library" property="og:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD002286.pub3/full" property="og:url"/> <meta content="article" property="og:type"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" property="og:image"/> <meta content="summary_large_image" name="twitter:card"/> <meta content="Feverfew for preventing migraine - Wider, B - 2015 | Cochrane Library" name="twitter:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD002286.pub3/full" name="twitter:url"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" name="twitter:image"/> <meta content="initial-scale=1.0, width=device-width" name="viewport"/> <meta content="10.1002/14651858.CD002286.pub3" name="dc.identifier" scheme="DOI"/> <meta content="Feverfew for preventing migraine" name="citation_title"/> <meta content="Barbara Wider" name="citation_author"/> <meta content="barbara.wider@uit.no" name="citation_author_email"/> <meta content="Max H Pittler" name="citation_author"/> <meta content="Hospital for Cancer Research" name="citation_author_institution"/> <meta content="Edzard Ernst" name="citation_author"/> <meta content="Peninsula Medical School, University of Exeter" name="citation_author_institution"/> <meta content="Cochrane Database of Systematic Reviews" name="citation_journal_title"/> <meta content="John Wiley &amp; Sons, Ltd" name="citation_publisher"/> <meta content="4" name="citation_issue"/> <meta content="10.1002/14651858.CD002286.pub3" name="citation_doi"/> <meta content="2015" name="citation_date"/> <meta content="2015/04/20" name="citation_online_date"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD002286.pub3/abstract" name="citation_abstract_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD002286.pub3/full" name="citation_fulltext_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD002286.pub3/pdf/full" name="citation_pdf_url"/> <meta content="1465-1858" name="citation_issn"/> <meta content="en" name="citation_language"/> <meta content="Migraine Disorders [*prevention &amp; control]; *Phytotherapy; Plant Extracts [therapeutic use]; Randomized Controlled Trials as Topic; *Tanacetum parthenium" name="citation_keywords"/> <link href="https://fonts.googleapis.com/css?family=Source+Sans+Pro:400,700,600,900" rel="stylesheet"/> <script src="https://cmp.osano.com/AzZdRbSORDOOzF9W/d594efc1-9663-477d-9528-6576640e64fd/osano.js"></script> <style> .osano-cm-widget{display: none;} </style> <script src="https://static.addtoany.com/menu/page.js"></script> <script async="" charset="utf-8" src="https://platform.twitter.com/widgets.js"></script> <script async="async" src="//script.crazyegg.com/pages/scripts/0056/6375.js" type="text/javascript"></script> <script type="text/javascript">window.dataLayer={};var xtend=function(){var a={};var b=false;var c=0;var d=arguments.length;if(Object.prototype.toString.call(arguments[0])==="[object Boolean]"){b=arguments[0];c++}var f=function(g){for(var h in g){if(Object.prototype.hasOwnProperty.call(g,h)){if(b&&Object.prototype.toString.call(g[h])==="[object Object]"){a[h]=xtend(true,a[h],g[h])}else{a[h]=g[h]}}}};for(;c<d;c++){var e=arguments[c];f(e)}return a};</script> <!-- Global site tag (gtag.js) - Google Analytics --> <script src="https://www.googletagmanager.com/gtag/js?id=UA-189672-63&amp;l=gDataLayer"></script> <script>window.gDataLayer=window.gDataLayer||[];function gtag(){gDataLayer.push(arguments)}gtag("js",new Date());gtag("config","UA-189672-63");</script> <script type="text/javascript">var o={auth:{customerIds:[],individualId:null,brandedCustomer:null,roles:["Guest"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <script type="text/javascript">var o={page:{siteSection:"Content",languageCode:"en",cms:{pageTitle:"Content"}}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <meta content="text/html; charset=utf-8" http-equiv="content-type"/> <link href="https://www.cochranelibrary.com/cochrane-theme/images/favicon.ico" rel="Shortcut Icon"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD002286.pub3&amp;doi=10.1002/14651858.CD002286.pub3&amp;type=cdsr&amp;contentLanguage=" rel="canonical"/> <link href="https://www.cochranelibrary.com/zh/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD002286.pub3&amp;doi=10.1002/14651858.CD002286.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANS" rel="alternate"/> <link href="https://www.cochranelibrary.com/zh_HANT/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD002286.pub3&amp;doi=10.1002/14651858.CD002286.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANT" rel="alternate"/> <link href="https://www.cochranelibrary.com/hr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD002286.pub3&amp;doi=10.1002/14651858.CD002286.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="hr-HR" rel="alternate"/> <link href="https://www.cochranelibrary.com/nl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD002286.pub3&amp;doi=10.1002/14651858.CD002286.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="nl-NL" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD002286.pub3&amp;doi=10.1002/14651858.CD002286.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="x-default" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD002286.pub3&amp;doi=10.1002/14651858.CD002286.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="en-US" rel="alternate"/> <link href="https://www.cochranelibrary.com/fr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD002286.pub3&amp;doi=10.1002/14651858.CD002286.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="fr-FR" rel="alternate"/> <link href="https://www.cochranelibrary.com/de/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD002286.pub3&amp;doi=10.1002/14651858.CD002286.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="de-DE" rel="alternate"/> <link href="https://www.cochranelibrary.com/hi/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD002286.pub3&amp;doi=10.1002/14651858.CD002286.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="hi-HI" rel="alternate"/> <link href="https://www.cochranelibrary.com/hu/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD002286.pub3&amp;doi=10.1002/14651858.CD002286.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="hu-HU" rel="alternate"/> <link href="https://www.cochranelibrary.com/in/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD002286.pub3&amp;doi=10.1002/14651858.CD002286.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="in-ID" rel="alternate"/> <link href="https://www.cochranelibrary.com/ja/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD002286.pub3&amp;doi=10.1002/14651858.CD002286.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ja-JP" rel="alternate"/> <link href="https://www.cochranelibrary.com/ko/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD002286.pub3&amp;doi=10.1002/14651858.CD002286.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ko-KR" rel="alternate"/> <link href="https://www.cochranelibrary.com/ms/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD002286.pub3&amp;doi=10.1002/14651858.CD002286.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ms-MY" rel="alternate"/> <link href="https://www.cochranelibrary.com/fa/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD002286.pub3&amp;doi=10.1002/14651858.CD002286.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="fa-IR" rel="alternate"/> <link href="https://www.cochranelibrary.com/pl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD002286.pub3&amp;doi=10.1002/14651858.CD002286.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="pl-PL" rel="alternate"/> <link href="https://www.cochranelibrary.com/pt/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD002286.pub3&amp;doi=10.1002/14651858.CD002286.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="pt-PT" rel="alternate"/> <link href="https://www.cochranelibrary.com/ro/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD002286.pub3&amp;doi=10.1002/14651858.CD002286.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ro-RO" rel="alternate"/> <link href="https://www.cochranelibrary.com/ru/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD002286.pub3&amp;doi=10.1002/14651858.CD002286.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ru-RU" rel="alternate"/> <link href="https://www.cochranelibrary.com/es/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD002286.pub3&amp;doi=10.1002/14651858.CD002286.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="es-ES" rel="alternate"/> <link href="https://www.cochranelibrary.com/ta/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD002286.pub3&amp;doi=10.1002/14651858.CD002286.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ta-IN" rel="alternate"/> <link href="https://www.cochranelibrary.com/th/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD002286.pub3&amp;doi=10.1002/14651858.CD002286.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="th-TH" rel="alternate"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" rel="stylesheet" type="text/css"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/aui.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" rel="stylesheet" type="text/css"/> <link href="/html/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772874000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/scolaris-content-display/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/notifications-portlet/notifications/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772751000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/html/portlet/login/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772901000" rel="stylesheet" type="text/css"/> <script type="text/javascript">var Liferay={Browser:{acceptsGzip:function(){return false},getMajorVersion:function(){return 80},getRevision:function(){return"537.36"},getVersion:function(){return"80.0"},isAir:function(){return false},isChrome:function(){return true},isFirefox:function(){return false},isGecko:function(){return true},isIe:function(){return false},isIphone:function(){return false},isLinux:function(){return true},isMac:function(){return false},isMobile:function(){return false},isMozilla:function(){return false},isOpera:function(){return false},isRtf:function(){return true},isSafari:function(){return true},isSun:function(){return false},isWap:function(){return false},isWapXhtml:function(){return false},isWebKit:function(){return true},isWindows:function(){return false},isWml:function(){return false}},Data:{NAV_SELECTOR:"#navigation",isCustomizationView:function(){return false},notices:[null]},ThemeDisplay:{getLayoutId:function(){return"7"},getLayoutURL:function(){return"https://www.cochranelibrary.com/en/content"},getParentLayoutId:function(){return"0"},isPrivateLayout:function(){return"false"},isVirtualLayout:function(){return false},getBCP47LanguageId:function(){return"en-US"},getCDNBaseURL:function(){return"https://www.cochranelibrary.com"},getCDNDynamicResourcesHost:function(){return""},getCDNHost:function(){return""},getCompanyId:function(){return"20155"},getCompanyGroupId:function(){return"20195"},getDefaultLanguageId:function(){return"en_US"},getDoAsUserIdEncoded:function(){return""},getLanguageId:function(){return"en_US"},getParentGroupId:function(){return"20182"},getPathContext:function(){return""},getPathImage:function(){return"/image"},getPathJavaScript:function(){return"/html/js"},getPathMain:function(){return"/en/c"},getPathThemeImages:function(){return"https://www.cochranelibrary.com/cochrane-theme/images"},getPathThemeRoot:function(){return"/cochrane-theme"},getPlid:function(){return"20757"},getPortalURL:function(){return"https://www.cochranelibrary.com"},getPortletSetupShowBordersDefault:function(){return true},getScopeGroupId:function(){return"20182"},getScopeGroupIdOrLiveGroupId:function(){return"20182"},getSessionId:function(){return""},getSiteGroupId:function(){return"20182"},getURLControlPanel:function(){return"/group/control_panel?refererPlid=20757"},getURLHome:function(){return"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane"},getUserId:function(){return"20159"},getUserName:function(){return""},isAddSessionIdToURL:function(){return false},isFreeformLayout:function(){return false},isImpersonated:function(){return false},isSignedIn:function(){return false},isStateExclusive:function(){return false},isStateMaximized:function(){return false},isStatePopUp:function(){return false}},PropsValues:{NTLM_AUTH_ENABLED:false}};var themeDisplay=Liferay.ThemeDisplay;Liferay.AUI={getAvailableLangPath:function(){return"available_languages.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513679709000"},getCombine:function(){return true},getComboPath:function(){return"/combo/?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513679709000&"},getFilter:function(){return"min"},getJavaScriptRootPath:function(){return"/html/js"},getLangPath:function(){return"aui_lang.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513679709000"},getStaticResourceURLParams:function(){return"?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513679709000"}};Liferay.authToken="FKeXZrqu";Liferay.currentURL="\x2fweb\x2fcochrane\x2fcontent\x3ftemplateType\x3dfull\x26urlTitle\x3d\x2fcdsr\x2fdoi\x2f10\x2e1002\x2f14651858\x2eCD002286\x2epub3\x26doi\x3d10\x2e1002\x2f14651858\x2eCD002286\x2epub3\x26type\x3dcdsr\x26contentLanguage\x3d";Liferay.currentURLEncoded="\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD002286\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD002286\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D";</script> <script src="/html/js/barebone.jsp?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;colorSchemeId=01&amp;minifierType=js&amp;minifierBundleId=javascript.barebone.files&amp;languageId=en_US&amp;b=6210&amp;t=1513679709000" type="text/javascript"></script> <script type="text/javascript"></script> <script type="text/javascript">var o={database:"CDSR",page:{pageType:"Article Full Text HTML"},article:{availableLanguage:["en","es","de","zh_HANT","ru","ko","ms","ja","hr","fa","fr","pl"],languageCode:"en",accessStatus:"delayed-free",doi:"10.1002/14651858.CD002286.pub3",title:"Feverfew for preventing migraine",firstPublishedDate:"Apr 20, 2015 12:00:00 AM",isCurrentVersion:true,editorialGroup:"Cochrane Pain, Palliative and Supportive Care Group",availableParts:["PDF Full","PDF Standard","PDF Abstract","HTML","Comments","Information","References","Stats","Related Content"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/custom.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" rel="stylesheet" type="text/css"/> <style type="text/css"></style> <script async="" src="https://assets.adobedtm.com/59640f9fa510/7cad07cf7779/launch-a215d9c51521.min.js"></script> <!--[if lt IE 9]> <script src="/cochrane-theme/vendor/respond/dest/respond.min.js?t=1738734064000" type="text/javascript"></script> <![endif]--> </head> <body class="yui3-skin-sam controls-visible guest-site signed-out public-page site"> <div class="site-container"> <a href="#main-content" id="skip-to-content">Skip to Content</a> <div class="cookie-message cookie-message--hidden system-message-container" id="js-cookie-message"> <div class="container"> <a aria-label="Close cookies message" class="fa fa-times js-cookie-close pull-right" href="#"></a> <div class="system-message-wrapper container"> <i aria-hidden="true" class="fa fa-exclamation-triangle"></i> <div class="system-message-title">Cookies</div> <div class="system-message-description"> <p> Our site uses cookies to improve your experience. You can find out more about our use of cookies in About Cookies, including instructions on how to turn off cookies if you wish to do so. By continuing to browse this site you agree to us using cookies as described in <a href="http://olabout.wiley.com/WileyCDA/Section/id-813473.html">About Cookies</a>. </p> <a class="btn secondary js-cookie-close js-cookie-accept" href="#">I accept</a> </div> </div> </div> </div> <script>document.body.className=document.body.className+" js_enabled";</script><header> <div class="container"> <div class="branding"> <h1 class="brand-container"> <a href="https://www.cochranelibrary.com/en/"> <span class="brand-name">The Cochrane Library</span> <img alt="Cochrane Library logo" class="brand-logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_logo.png" title="Cochrane Library"/> </a> </h1> <span class="additional-branding"> <p class="brand-message"> <em>Trusted evidence.</em> <em>Informed decisions.</em> <em>Better health.</em> </p> </span> </div> <div class="desktop-search basic-search-container"> <div class="desktop-search-form"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="owel__null__null" src="/scolaris-search/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=FKeXZrqu&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"/> <input name="facetDisplayName" type="hidden" value=""/> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD002286.pub3&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD002286.pub3';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<div class="search-tools-nav">
<a class="btn secondary" href="/en/browse-by-topic">Browse</a>
<a class="btn primary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
</div>
<a class="toggle-menu-switch" href="#"><i aria-hidden="true" class="fa fa-bars"></i> <div class="toggle-menu-text">Open menu</div></a>
</div>
<div class="auxiliary-container">
<div class="container">
<div class="header-auxiliary-menu">
<div class="auxiliary-menu-item language-selector">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="bvrs__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> Review language : English </a> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> Website language : English </a> </div> <div class="language-selector-modal-content" data-modal-title="Language selection" data-size="large" style="display: none;"> <div class="form-content language-selector-modal"> <div class="row-fluid"> <div> <table class="mytable" style="border: 1px solid #f0f0f0" width="90%"> <tbody> <tr class="row-box"> <td><i class="fa fa-file-text icon-size"></i></td> <td><h3>Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> </td> <td> <div> <select id="contentLanguageSelector" onchange="updateLang(this.value)"> <option class="content-language-option" data-languagecode="de" value="de"> Deutsch </option> <option class="content-language-option" data-languagecode="en" selected="" value="en"> English </option> <option class="content-language-option" data-languagecode="es" value="es"> Español </option> <option class="content-language-option" data-languagecode="fa" value="fa"> فارسی </option> <option class="content-language-option" data-languagecode="fr" value="fr"> Français </option> <option class="content-language-option" data-languagecode="hi" value="hi"> हिन्दी </option> <option class="content-language-option" data-languagecode="hr" value="hr"> Hrvatski </option> <option class="content-language-option" data-languagecode="id" value="id"> Bahasa Indonesia </option> <option class="content-language-option" data-languagecode="ja" value="ja"> 日本語 </option> <option class="content-language-option" data-languagecode="ko" value="ko"> 한국어 </option> <option class="content-language-option" data-languagecode="hu" value="hu"> Magyar </option> <option class="content-language-option" data-languagecode="ms" value="ms"> Bahasa Malaysia </option> <option class="content-language-option" data-languagecode="nl" value="nl"> Nederlands </option> <option class="content-language-option" data-languagecode="pl" value="pl"> Polski </option> <option class="content-language-option" data-languagecode="pt" value="pt"> Português </option> <option class="content-language-option" data-languagecode="ru" value="ru"> Русский </option> <option class="content-language-option" data-languagecode="ro" value="ro"> Română </option> <option class="content-language-option" data-languagecode="ta" value="ta"> தமிழ் </option> <option class="content-language-option" data-languagecode="th" value="th"> ภาษาไทย </option> <option class="content-language-option" data-languagecode="zh_HANT" value="zh_HANT"> 繁體中文 </option> <option class="content-language-option" data-languagecode="zh_HANS" value="zh_HANS"> 简体中文 </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> <tr class="row-box"> <td><i class="fa fa-globe icon-size"></i></td> <td> <div class="language-info"> <h3>Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> </div> </td> <td> <div class="language-dropdown"> <select id="portalLanguageSelector"> <option class="portal-language-selector" data-portallanguage="en" selected="" value="/en/cdsr/doi/10.1002/14651858.CD002286.pub3/full/en"> English </option> <option class="portal-language-selector" data-portallanguage="es" value="/es/cdsr/doi/10.1002/14651858.CD002286.pub3/full/es"> Español </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> </tbody> </table> </div> </div> <div style="text-align: right;"> <button class="btn primary btn-cancel" style="margin-left: 10px;" type="button">Cancel</button> <a class="btn secondary ok-btn" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<a class="auxiliary-menu-item signin last" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD002286.pub3%2Ffull" rel="nofollow">
<i class="icon fa fa-user"></i> Sign In
    </a>
<span class="auxiliary-container-extended"></span>
</div>
</div>
</div>
</header>
<div class="main-nav-wrapper">
<span class="main-nav-left-extended"></span>
<nav class="main container">
<ul>
<li class="nav-root-item parent">
<a href="#">Cochrane reviews<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_14" role="presentation">
<a aria-labelledby="layout_14" href="https://www.cochranelibrary.com/en/cdsr/reviews" role="menuitem">
            Search reviews (CDSR)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_15" role="presentation">
<a aria-labelledby="layout_15" href="https://www.cochranelibrary.com/en/cdsr/reviews/topics" role="menuitem">
            Browse reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_18" role="presentation">
<a aria-labelledby="layout_18" href="https://www.cochranelibrary.com/en/cdsr/table-of-contents" role="menuitem">
            Issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_17" role="presentation">
<a aria-labelledby="layout_17" href="https://www.cochranelibrary.com/en/cdsr/editorials" role="menuitem">
            Editorials
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_19" role="presentation">
<a aria-labelledby="layout_19" href="https://www.cochranelibrary.com/en/special-collections" role="menuitem">
            Special Collections
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_20" role="presentation">
<a aria-labelledby="layout_20" href="https://www.cochranelibrary.com/en/cdsr/supplements" role="menuitem">
            Supplements
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_121" role="presentation">
<a aria-labelledby="layout_121" href="https://www.cochranelibrary.com/en/about/about-cochrane-reviews" role="menuitem">
            About Cochrane reviews
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Searching for trials<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_254" role="presentation">
<a aria-labelledby="layout_254" href="https://www.cochranelibrary.com/en/search/releases" role="menuitem">
            What's new (search and CENTRAL)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_266" role="presentation">
<a aria-labelledby="layout_266" href="https://www.cochranelibrary.com/en/search-help" role="menuitem">
            Search help
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_252" role="presentation">
<a aria-labelledby="layout_252" href="https://www.cochranelibrary.com/en/search-help-quick-guides" role="menuitem">
            Search help quick guides
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_251" role="presentation">
<a aria-labelledby="layout_251" href="https://www.cochranelibrary.com/en/search-faqs" role="menuitem">
            Search FAQs
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_114" role="presentation">
<a aria-labelledby="layout_114" href="https://www.cochranelibrary.com/en/central/about-central" role="menuitem">
            About CENTRAL
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_115" role="presentation">
<a aria-labelledby="layout_115" href="https://www.cochranelibrary.com/en/central/central-creation" role="menuitem">
            How CENTRAL is created
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_241" role="presentation">
<a aria-labelledby="layout_241" href="https://www.cochranelibrary.com/en/retracted-trials" role="menuitem">
            Retracted publications in CENTRAL
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Clinical Answers<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_29" role="presentation">
<a aria-labelledby="layout_29" href="https://www.cochranelibrary.com/en/cca" role="menuitem">
            Browse Clinical Answers
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_91" role="presentation">
<a aria-labelledby="layout_91" href="https://www.cochranelibrary.com/en/cca/about" role="menuitem">
            About Clinical Answers
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">About<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_116" role="presentation">
<a aria-labelledby="layout_116" href="https://www.cochranelibrary.com/en/about/about-cochrane-library" role="menuitem">
            About the Cochrane Library
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_13" role="presentation">
<a aria-labelledby="layout_13" href="https://www.cochranelibrary.com/en/cdsr/about-cdsr" role="menuitem">
            Cochrane Database of Systematic reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_198" role="presentation">
<a aria-labelledby="layout_198" href="https://www.cochranelibrary.com/en/cdsr/editorial-policies" role="menuitem">
            Editorial policies
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_92" role="presentation">
<a aria-labelledby="layout_92" href="https://www.cochranelibrary.com/en/about/author-information" role="menuitem">
            Information for authors
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_212" role="presentation">
<a aria-labelledby="layout_212" href="https://www.cochranelibrary.com/en/about-pico" role="menuitem">
            About PICO
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_207" role="presentation">
<a aria-labelledby="layout_207" href="https://www.cochranelibrary.com/en/about/about-translations" role="menuitem">
            About translations
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_188" role="presentation">
<a aria-labelledby="layout_188" href="https://www.cochranelibrary.com/en/about/releases" role="menuitem">
            What's new
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_216" role="presentation">
<a aria-labelledby="layout_216" href="https://www.cochranelibrary.com/en/data" role="menuitem">
            Data reuse
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_235" role="presentation">
<a aria-labelledby="layout_235" href="https://www.cochranelibrary.com/en/about/about-cochrane-library/editorial-board" role="menuitem">
            Cochrane Library Editorial Board
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Help<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_259" role="presentation">
<a aria-labelledby="layout_259" href="https://m.info.wiley.com/webApp/cochranenewsletter?id=0" role="menuitem">
            Newsletter
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_177" role="presentation">
<a aria-labelledby="layout_177" href="https://www.wiley.com/en-us/customer-success/cochrane-library-training-hub" role="menuitem">
            Cochrane Library Training
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_44" role="presentation">
<a aria-labelledby="layout_44" href="https://www.cochranelibrary.com/en/help/access" role="menuitem">
            Access
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_150" role="presentation">
<a aria-labelledby="layout_150" href="https://www.cochranelibrary.com/en/help/permissions" role="menuitem">
            Permissions and reprints
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_93" role="presentation">
<a aria-labelledby="layout_93" href="https://www.cochranelibrary.com/en/help/media" role="menuitem">
            Media information
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_97" role="presentation">
<a aria-labelledby="layout_97" href="https://www.cochranelibrary.com/en/help/contact-us" role="menuitem">
            Contact us
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_125" role="presentation">
<a aria-labelledby="layout_125" href="https://www.cochranelibrary.com/en/about/terms-and-conditions" role="menuitem">
            Terms and conditions
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_176" role="presentation">
<a aria-labelledby="layout_176" href="https://cochranesupport.wiley.com/s/article/cochrane-library-known-issues" role="menuitem">
            Known issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_270" role="presentation">
<a aria-labelledby="layout_270" href="https://www.cochranelibrary.com/search-help" role="menuitem">
            Search help
        </a>
</li>
</ul>
</li>
<li class="about-link"><a href="https://www.cochrane.org/about-us" target="_blank"><span>About Cochrane</span><i class="fa fa-caret-right"></i></a></li>
</ul>
</nav>
</div>
<div class="portlet-boundary portlet-boundary_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_">
<span id="p_scolariscontentlanguagebanner_WAR_scolarislanguageportlet"></span>
<section class="portlet" id="portlet_scolariscontentlanguagebanner_WAR_scolarislanguageportlet">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Language\x20Banner\x20Portlet')">
<img alt="" id="etlj__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Language Banner Portlet</span> </span> <span class="portlet-title-text">Scolaris Content Language Banner Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentlanguagebanner_WAR_scolarislanguageportlet" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="" id="content">
<div class="columns-1" id="main-content" role="main">
<div class="portlet-layout row-fluid">
<div class="portlet-column portlet-column-only span12" id="column-1">
<div class="portlet-dropzone portlet-column-content portlet-column-content-only" id="layout-column_column-1">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="rjus__column1__0" src="/scolaris-content-display/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="publication cdsr container"> <div class="article-navigation-container" id="cdsr-nav"> <nav class="article-navigation"> <ul class="tools-row"> <li> <li class="tools pdf pulldown-menu readcube-menu closed en_US"> <a class="pulldown-menu-trigger" href="#0"> <span class="pdf-icon"> <i class="icon fa fa-file-pdf-o"></i> <span>Download PDF</span> </span> <i aria-hidden="true" class="fa fa-caret-down"></i> </a> <ul class="pulldown-menu-items"> <li class=""> <a class="download media pdf-link-full pdf-link" href="/cdsr/doi/10.1002/14651858.CD002286.pub3/pdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> <a class="download media pdf-link-full readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD002286.pub3/epdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> </li> <li class=""> <a class="download media pdf-link-abstract pdf-link" href="/cdsr/doi/10.1002/14651858.CD002286.pub3/pdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> <a class="download media pdf-link-abstract readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD002286.pub3/epdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> </li> </ul> </li> <li class="tools cite cite-article-link" data-article-id="CD002286.PUB3" data-modal-title="Cite this review"> <span><i aria-hidden="true" class="icon fa fa-share"></i></span> <span>Cite this review</span> </li> </li> </ul> <ul class="tools-row tools-secondary"> <li> <li class="tools print print-cdsr-link" data-content-language="en" data-indicator-tooltip="scolaris.print.modal.language.tooltip.en" data-print-options="[{&quot;param&quot;: &quot;abstract&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Abstract&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;چکیده&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;Résumé scientifique&quot;},{&quot;language&quot;:&quot;ko&quot;,&quot;title&quot;:&quot;초록&quot;}]},{&quot;param&quot;: &quot;pls&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Plain language summary&quot;},{&quot;language&quot;:&quot;de&quot;,&quot;title&quot;:&quot;Laienverständliche Zusammenfassung&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen en términos sencillos&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;خلاصه به زبان ساده&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;Résumé simplifié&quot;},{&quot;language&quot;:&quot;hr&quot;,&quot;title&quot;:&quot;Laički sažetak&quot;},{&quot;language&quot;:&quot;ja&quot;,&quot;title&quot;:&quot;一般語訳&quot;},{&quot;language&quot;:&quot;ko&quot;,&quot;title&quot;:&quot;쉬운 말 요약&quot;},{&quot;language&quot;:&quot;ms&quot;,&quot;title&quot;:&quot;Ringkasan bahasa mudah&quot;},{&quot;language&quot;:&quot;pl&quot;,&quot;title&quot;:&quot;Streszczenie prostym językiem&quot;},{&quot;language&quot;:&quot;ru&quot;,&quot;title&quot;:&quot;Резюме на простом языке&quot;},{&quot;language&quot;:&quot;zh_HANT&quot;,&quot;title&quot;:&quot;淺顯易懂的口語結論&quot;}]},{&quot;param&quot;: &quot;conclusions&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors' conclusions&quot;}]},{&quot;param&quot;: &quot;background&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Background&quot;}]},{&quot;param&quot;: &quot;objectives&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Objectives&quot;}]},{&quot;param&quot;: &quot;methods&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Methods&quot;}]},{&quot;param&quot;: &quot;results&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Results&quot;}]},{&quot;param&quot;: &quot;discussion&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Discussion&quot;}]},{&quot;param&quot;: &quot;references&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;References&quot;}]},{&quot;param&quot;: &quot;appendices&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Appendices&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Search strategies&quot;}]},{&quot;param&quot;: &quot;characteristics&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Characteristics of studies&quot;}]},{&quot;param&quot;: &quot;information&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Information&quot;}]},{&quot;param&quot;: &quot;authors&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors&quot;}]},{&quot;param&quot;: &quot;history&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;}]}]" data-print-urlbase="/cdsr/doi/10.1002/14651858.CD002286.pub3/print"> <span><i class="icon fa fa-print"></i></span> <span>Print</span> </li> <li class="js-old-version-modal-trigger tools comments comment-on-review" data-article-id="CD002286.PUB3" data-english-only-message="Please note, that commenting is available in English only. Apologies for any inconvenience." data-href="/cdsr/doi/10.1002/14651858.CD002286.pub3/read-comments" data-new-version="" id="comment-on-review"> <span class="comment-icon"><i class="icon fa fa-comment"></i></span> <span class="comments-count">0</span> <span>Comment</span> </li> <li class="tools share-cdsr-link" data-share-url="/cdsr/doi/10.1002/14651858.CD002286.pub3/full"> <span><i class="icon fa fa-share-alt"></i></span> <span>Share</span> </li> <li class="tools follow"> <span class="article-not-followed cochrane-link signin follow-wrapper"> <span> <i class="icon fa fa-plus"></i> </span> <span> Follow </span> </span> </li> </li> </ul> <div class="metrics-wrapper"> <div class="metrics-count"> <span>Full text views: </span> <span>10836 <i class="icon fa fa-info-circle custom-tooltip" style="padding-left: 2px;color: #962d91;" title="Usage represents full text views on Cochrane Library since January 2022 or 2023. For articles published after this date, the usage represents views since the article was first published on Cochrane Library."> </i> </span> </div> </div> <div class="metrics-wrapper nav-link-section"> <div class="altmetric-embed" data-badge-type="1" data-condensed="true" data-doi="10.1002/14651858.CD002286.pub3" data-link-target="_blank"></div> <div class="inline-status-wrapper guidelines-count" data-count-plural="Cited in $1 guidelines" data-count-single="Cited in 1 guideline"> <a href="related-content#guidelines_data" title="Guidelines"></a> </div> </div> <ul class="nav-section-header"> <li> <h3>Contents</h3> </li> </ul> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD002286.pub3/full"> Abstract </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD002286.pub3/full#pico"> PICOs </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD002286.pub3/full#CD002286-abs-0002"> Plain language summary </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD002286.pub3/full#CD002286-sec-0060"> Authors' conclusions </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD002286.pub3/full#CD002286-sec-0008"> Background </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD002286.pub3/full#CD002286-sec-0013"> Objectives </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD002286.pub3/full#CD002286-sec-0014"> Methods </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD002286.pub3/full#CD002286-sec-0036"> Results </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD002286.pub3/full#CD002286-sec-0050"> Discussion </a> </li> <li class="cdsr-nav-link"> <a class="figures-and-tables-link" href="/cdsr/doi/10.1002/14651858.CD002286.pub3/#"> Figures and tables </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD002286.pub3/references"> References </a> </li> </ul> <div class="nav-section-header"> <h3>Supplementary materials</h3> </div> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD002286.pub3/appendices#CD002286-sec-0064"> Search strategies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD002286.pub3/references#characteristicStudies"> Characteristics of studies </a> </li> </ul> <ul class="tools-row"> <li> </li> </ul> <ul class="nav-section-header"> <li><h3>Related</h3></li> </ul> <ul class="linked-content linked-content-dropdown" id="linked-content-articles" tabindex="0"> <li class="linked-cca" data-type="cca"> <div class="linked-content-section"> <span class="linked-type">Cochrane Clinical Answers<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-editorials" data-type="editorial"> <div class="linked-content-section"> <span class="linked-type">Editorials<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-podcasts" data-type="podcast"> <div class="linked-content-section"> <span class="linked-type">Podcasts<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-sc" data-type="sc"> <div class="linked-content-section"> <span class="linked-type">Special Collections<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> </ul> <div class="nav-section-header"> <h3>About this review</h3> </div> <ul class="nav-long-form nav-info nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD002286.pub3/information"> <i> <svg viewbox="0 0 24 24"> <path d="M11,9H13V7H11M12,20C7.59,20 4,16.41 4,12C4,7.59 7.59,4 12,4C16.41,4 20,7.59 20,12C20,16.41 16.41,20 12,20M12,2A10,10 0 0,0 2,12A10,10 0 0,0 12,22A10,10 0 0,0 22,12A10,10 0 0,0 12,2M11,17H13V11H11V17Z"></path> </svg> </i> Information </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD002286.pub3/information#authors"> <i> <svg viewbox="0 0 24 24"> <path d="M12,5.5A3.5,3.5 0 0,1 15.5,9A3.5,3.5 0 0,1 12,12.5A3.5,3.5 0 0,1 8.5,9A3.5,3.5 0 0,1 12,5.5M5,8C5.56,8 6.08,8.15 6.53,8.42C6.38,9.85 6.8,11.27 7.66,12.38C7.16,13.34 6.16,14 5,14A3,3 0 0,1 2,11A3,3 0 0,1 5,8M19,8A3,3 0 0,1 22,11A3,3 0 0,1 19,14C17.84,14 16.84,13.34 16.34,12.38C17.2,11.27 17.62,9.85 17.47,8.42C17.92,8.15 18.44,8 19,8M5.5,18.25C5.5,16.18 8.41,14.5 12,14.5C15.59,14.5 18.5,16.18 18.5,18.25V20H5.5V18.25M0,20V18.5C0,17.11 1.89,15.94 4.45,15.6C3.86,16.28 3.5,17.22 3.5,18.25V20H0M24,20H20.5V18.25C20.5,17.22 20.14,16.28 19.55,15.6C22.11,15.94 24,17.11 24,18.5V20Z"></path> </svg> </i> Authors </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD002286.pub3/information#history"> <i> <svg viewbox="0 0 24 24"> <path d="M13.5,8H12V13L16.28,15.54L17,14.33L13.5,12.25V8M13,3A9,9 0 0,0 4,12H1L4.96,16.03L9,12H6A7,7 0 0,1 13,5A7,7 0 0,1 20,12A7,7 0 0,1 13,19C11.07,19 9.32,18.21 8.06,16.94L6.64,18.36C8.27,20 10.5,21 13,21A9,9 0 0,0 22,12A9,9 0 0,0 13,3"></path> </svg> </i> Version history </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD002286.pub3/information#keywords"> <i> <svg viewbox="0 0 24 24"> <path d="M11 3C10.18 3 9.44 3.5 9.14 4.27L3.64 18.27C3.12 19.58 4.09 21 5.5 21H7.75C8.59 21 9.33 20.5 9.62 19.7L10.26 18H13.74L14.38 19.7C14.67 20.5 15.42 21 16.25 21H18.5C19.91 21 20.88 19.58 20.36 18.27L14.86 4.27C14.56 3.5 13.82 3 13 3M11 5H13L18.5 19H16.25L15.12 16H8.87L7.75 19H5.5M12 7.67L9.62 14H14.37Z"></path> </svg> </i> Keywords (MeSH, PICOs) </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD002286.pub3/related-content"> <i class="icon fa fa-sitemap fa-rotate-270"></i> Related content </a> </li> <li class="cdsr-nav-link translation-notes-link"> <a href="/cdsr/doi/10.1002/14651858.CD002286.pub3/#"> <i> <svg viewbox="0 0 24 24"> <path d="M12.87,15.07L10.33,12.56L10.36,12.53C12.1,10.59 13.34,8.36 14.07,6H17V4H10V2H8V4H1V6H12.17C11.5,7.92 10.44,9.75 9,11.35C8.07,10.32 7.3,9.19 6.69,8H4.69C5.42,9.63 6.42,11.17 7.67,12.56L2.58,17.58L4,19L9,14L12.11,17.11L12.87,15.07M18.5,10H16.5L12,22H14L15.12,19H19.87L21,22H23L18.5,10M15.88,17L17.5,12.67L19.12,17H15.88Z"></path> </svg> </i> Translation notes </a> </li> <li class="cdsr-nav-link"> <a class="request-permissions" data-copyright="Copyright © 2015 The Cochrane Collaboration. Published by John Wiley &amp; Sons, Ltd." data-creative-commons="false" href="/cdsr/doi/10.1002/14651858.CD002286.pub3/#"> <span class="request-permissions-icon"></span> Request permissions </a> </li> <li class="cdsr-nav-link"> <a href="/data"> <i class="icon fa fa-database"></i> Request data reuse </a> </li> </ul> </nav> </div> <article> <div class="cdsr-header-top"> <div class="cdsr-header-left"> <a class="publish-database" href="/">Cochrane Database of Systematic reviews</a> <span class="publish-type">Review - Intervention</span> </div> <div class="cdsr-header-right"> </div> </div> <header class="publication-header"> <h1 class="publication-title" lang="en">Feverfew for preventing migraine</h1> <div class="publication-metadata-block"> <div class="publication-authors"> <div class="publish-meta-wrapper"> <ul class="authors"> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD002286.pub3/information#CD002286-cr-0004"><i class="icon corresponding-author fa fa-envelope"></i>Barbara Wider</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD002286.pub3/information#CD002286-cr-0005">Max H Pittler</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD002286.pub3/information#CD002286-cr-0006">Edzard Ernst</a></li> </ul> <span class="author declaration"> <a class="declarationsOfInterestLink" href="/cdsr/doi/10.1002/14651858.CD002286.pub3/information/en#CD002286-sec-0072">Authors' declarations of interest</a> </span> </div> </div> </div> <div class="publication-metadata-block"> <p> <span class="publish-date">Version published: 20 April 2015 </span> <a class="whatsNewLink" href="/cdsr/doi/10.1002/14651858.CD002286.pub3/information/en#versionTable">Version history</a> </p> <div class="doi-header"> <a href="https://doi.org/10.1002/14651858.CD002286.pub3">https://doi.org/10.1002/14651858.CD002286.pub3</a> </div> </div> </header> <div class="publication-control-bar"> <span class="publication-control-button publication-control-collapse"> Collapse all </span> <span class="publication-control-button publication-control-expand"> Expand all </span> </div> <section class="abstract"> <div class="section-header section-collapse-header" id="CD002286-abs-0001" lang="en"> <h2 class="title section-collapse-title"> Abstract <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD002286-abs-0001">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD002286-abs-0016">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD002286-abs-0011">فارسی</a> </li> <li class="section-language"> <a class="" href="full/fr#CD002286-abs-0013">Français</a> </li> <li class="section-language"> <a class="" href="full/ko#CD002286-abs-0006">한국어</a> </li> </nav> </div> </div> <div class="abstract full_abstract" id="CD002286-abs-0001" lang="en"> <section id="CD002286-sec-0001"> <h3 class="title" id="CD002286-sec-0001">Background</h3> <p>This review is an update of a previously published review in the Cochrane Database of Systematic Reviews on 'Feverfew for preventing migraine' (2004, Issue 1). Feverfew (<i>Tanacetum parthenium L.</i>) extract is a herbal remedy, which has been used for preventing attacks of migraine. </p> </section> <section id="CD002286-sec-0002"> <h3 class="title" id="CD002286-sec-0002">Objectives</h3> <p>To systematically review the evidence from double‐blind randomised controlled trials (RCTs) assessing the clinical efficacy and safety of feverfew monopreparations versus placebo for preventing migraine. </p> </section> <section id="CD002286-sec-0003"> <h3 class="title" id="CD002286-sec-0003">Search methods</h3> <p>For this updated version of the review we searched CENTRAL, MEDLINE, EMBASE and AMED to January 2015. We contacted manufacturers of feverfew and checked the bibliographies of identified articles for further trials. </p> </section> <section id="CD002286-sec-0004"> <h3 class="title" id="CD002286-sec-0004">Selection criteria</h3> <p>We included randomised, placebo‐controlled, double‐blind trials assessing the efficacy of feverfew monopreparations for preventing migraine in patients of any age. We included trials using clinical outcome measures, while we excluded trials focusing exclusively on physiological parameters. There were no restrictions regarding the language of publication. </p> </section> <section id="CD002286-sec-0005"> <h3 class="title" id="CD002286-sec-0005">Data collection and analysis</h3> <p>We systematically extracted data on patients, interventions, methods, outcome measures, results and adverse events. We assessed risk of bias using the Cochrane 'Risk of bias' tool and evaluated methodological quality using the Oxford Quality Scale developed by Jadad and colleagues. Two review authors (BW and MHP for this update, MHP and EE for the original version) independently selected studies, assessed methodological quality and extracted data. We resolved disagreements concerning evaluation of individual trials through discussion. </p> </section> <section id="CD002286-sec-0006"> <h3 class="title" id="CD002286-sec-0006">Main results</h3> <p>We identified one new study for this update, resulting in six trials (561 patients) meeting the inclusion criteria. Five of the six trials reported on the main outcome, migraine frequency. Although five of the trials were generally of good methodological quality, all studies were either of unclear or high risk of bias with regards to sample size. Pooled analysis of the results was not possible due to the lack of common outcome measures and heterogeneity between studies in terms of participants, interventions and designs. </p> <p>The most recent trial added to this version of the review is rigorous and larger (n = 218), using a stable feverfew extract at a dose determined by a previous dose‐finding trial. It reports that feverfew reduced migraine frequency by 1.9 attacks from 4.8 to 2.9 and placebo by 1.3 from to 4.8 to 3.5 per month, resulting in a difference in effect between feverfew and placebo of 0.6 attacks per month. For the secondary outcome measures intensity and duration of migraine attacks, incidence and severity of nausea and vomiting, and global assessment no statistically significant differences were reported. Results of previous trials are not convincing: three trials reporting positive effects of feverfew are all of small sample size (17 to 60 participants), while two rigorous trials (n = 50, 147) did not find significant differences between feverfew and placebo. Only mild and transient adverse events, most commonly gastrointestinal complaints and mouth ulcers, were reported in the included trials. </p> </section> <section id="CD002286-sec-0007"> <h3 class="title" id="CD002286-sec-0007">Authors' conclusions</h3> <p>Since the last version of this review, one larger rigorous study has been included, reporting a difference in effect between feverfew and placebo of 0.6 attacks per month. This adds some positive evidence to the mixed and inconclusive findings of the previous review. However, this constitutes low quality evidence, which needs to be confirmed in larger rigorous trials with stable feverfew extracts and clearly defined migraine populations before firm conclusions can be drawn. It appears from the data reviewed that feverfew is not associated with any major safety concerns. </p> </section> </div> </section> <section class="pico-section" id="pico"> <h2 class="title section-collapse-title">PICOs <i class="icon fa fa-info-circle" title="The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome."></i> <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-content" style="display: block;"> <h3 class="keyword-heading">PICOs</h3> <div class="pico-table"> <div class="pico-column Population"> <h6>Population<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Intervention"> <h6>Intervention<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Comparison"> <h6>Comparison<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Outcome"> <h6>Outcome<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> </div> <div class="pico-information"> <p><i class="icon fa fa-info-circle"></i> The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome.</p> <p>See more on using PICO in the <a href="https://training.cochrane.org/handbook/current/chapter-02#section-2-3">Cochrane Handbook</a>.</p> </div> </div> </section> <section class="pls"> <div class="section-header section-collapse-header" id="CD002286-abs-0002" lang="en"> <h2 class="title section-collapse-title"> Plain language summary <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD002286-abs-0002">English</a> </li> <li class="section-language"> <a class="" href="full/de#CD002286-abs-0003">Deutsch</a> </li> <li class="section-language"> <a class="" href="full/es#CD002286-abs-0017">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD002286-abs-0012">فارسی</a> </li> <li class="section-language"> <a class="" href="full/fr#CD002286-abs-0014">Français</a> </li> <li class="section-language"> <a class="" href="full/hr#CD002286-abs-0010">Hrvatski</a> </li> <li class="section-language"> <a class="" href="full/ja#CD002286-abs-0009">日本語</a> </li> <li class="section-language"> <a class="" href="full/ko#CD002286-abs-0007">한국어</a> </li> <li class="section-language"> <a class="" href="full/ms#CD002286-abs-0008">Bahasa Malaysia</a> </li> <li class="section-language"> <a class="" href="full/pl#CD002286-abs-0015">Polski</a> </li> <li class="section-language"> <a class="" href="full/ru#CD002286-abs-0005">Русский</a> </li> <li class="section-language"> <a class="" href="full/zh_HANT#CD002286-abs-0004">繁體中文</a> </li> </nav> </div> </div> <div class="abstract abstract_plainLanguageSummary" id="CD002286-abs-0002" lang="en"> <h3>Feverfew for preventing migraine</h3> <p>Migraine is a common, disabling headache disorder. Feverfew (<i>Tanacetum parthenium L.</i>) is a herbal remedy used for the prevention of migraine attacks. For this update of a previous Cochrane review, we reviewed the available evidence up to January 2015 for or against feverfew in the prevention of migraine and found six studies including 561 participants. Generally the studies were heterogeneous and their results were mixed. The previous version of this review showed no clear benefit of feverfew compared with placebo. We added a new study, which is larger and was carried out to high standards, to this review. It showed that feverfew reduced migraine frequency by a little more than half a migraine (0.6) per month compared to placebo. There was no difference in how severe the pain was, or how long it lasted. These results come from a single study of moderate size, therefore they must be viewed with caution until they are confirmed in other rigorous studies. No major adverse effects were associated with feverfew in the included studies. </p> </div> </section> <section id="vls" style="display: none"> <div class="section-header section-collapse-header"> <h2 class="title section-collapse-title">Visual summary<i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i></h2> </div> <a href="" target="_blank"><img alt="visual summary" src=""/></a> </section> <section class="conclusions"> <div class="section-header section-collapse-header" id="CD002286-sec-0060" lang="en"> <h2 class="title section-collapse-title"> Authors' conclusions <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="authorsConclusions" lang="en"> <div class="section-header" id="CD002286-sec-0060"></div> <h3 class="title" id="CD002286-sec-0061">Implications for practice</h3> <section id="CD002286-sec-0061"> <p>Overall there is low quality evidence that feverfew is effective in migraine prevention. The most recent study, a medium‐sized, rigorously executed study, demonstrated a decrease in migraine frequency of 0.6 attacks per month with feverfew compared with placebo. Results from previous studies, which were smaller and used different designs and interventions, were mixed and not convincing. Use of feverfew appears to be well tolerated and no major safety issues have been reported. </p> </section> <h3 class="title" id="CD002286-sec-0062">Implications for research</h3> <section id="CD002286-sec-0062"> <p>These cautiously positive results need to be confirmed in larger trials, which need to be rigorously executed and reported. Efforts should be undertaken to minimise heterogeneity between trials by using clearly defined outcome measures and methods to capture them as described in the International Headache Society (IHS) guidelines (<a href="./references#CD002286-bbs2-0049" title="Tfelt-HansenP , PascualJ , RamadanN , DahlöfC , D'AmicoD , DienerHC , et al, International Headache Society Clinical Trials Subcommittee. Guidelines for controlled trials of drugs in migraine: third edition. A guide for investigators. Cephalalgia2012;32:6-38.">Tfelt‐Hansen 2012</a>). Future trials should use stable, standardised feverfew extracts and clearly defined migraine populations. </p> </section> </section> </section> <section class="background"> <div class="section-header section-collapse-header" id="CD002286-sec-0008" lang="en"> <h2 class="title section-collapse-title"> Background <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="background" lang="en"> <div class="section-header" id="CD002286-sec-0008"></div> <p>This is an update of a previously published review in the Cochrane Database of Systematic Reviews (2004, Issue 1) on feverfew for preventing migraine (<a href="./references#CD002286-bbs2-0055" title="PittlerMH , ErnstE . Feverfew for preventing migraine. Cochrane Database of Systematic Reviews2004, Issue 1. [DOI: 10.1002/14651858.CD002286.pub2]">Pittler 2004</a>). </p> <section id="CD002286-sec-0009"> <h3 class="title" id="CD002286-sec-0009">Description of the condition</h3> <p>Migraine is a common, incapacitating primary headache disorder. According to the International Headache Society it can be classified into two major sub‐types: migraine without aura and migraine with aura (previously called common and classical migraine) (<a href="./references#CD002286-bbs2-0032" title="Headache Classification Committee of the International Headache Society (IHS). The International Classification of Headache Disorders, 3rd edition (beta version). Cephalalgia2013;33:629-808.">IHS 2013</a>). Migraine without aura manifests in attacks lasting 4 to 72 hours; the headaches are characterised by their unilateral location, pulsating quality, moderate or severe intensity, aggravation by routine physical activity and association with nausea and/or photophobia and phonophobia. Migraine with aura is primarily characterised by the focal neurological symptoms that usually precede the headache. Aura usually develops gradually over 5 to 20 minutes and last for less than 60 minutes. Headache with or without the features of migraine may accompany or follow the aura symptoms within 60 minutes (<a href="./references#CD002286-bbs2-0032" title="Headache Classification Committee of the International Headache Society (IHS). The International Classification of Headache Disorders, 3rd edition (beta version). Cephalalgia2013;33:629-808.">IHS 2013</a>; <a href="./references#CD002286-bbs2-0052" title="World Health Organization. Headache disorders. Fact sheet N°277. http://www.who.int/mediacentre/factsheets/fs277/en/ 2012 (accessed 29 January 2014).">World Health Organization 2012</a>). </p> <p>Apart from presenting a considerable personal burden with regards to pain, functional health and well being, the prevalence and socio‐economic impact of migraine are also significant. The Global Burden of Disease Study classified migraine as the third most common disorder to affect individuals globally in 2010, with a prevalence of 14.7% (<a href="./references#CD002286-bbs2-0050" title="VosT , FlaxmanAD , NaghaviM , LozanoR , MichaudC , EzzatiM , et al. Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet2012;380:2163-96.">Vos 2012</a>). Migraine was also ranked seventh highest among specific causes of disability globally (<a href="./references#CD002286-bbs2-0045" title="SteinerTJ , StovnerLJ , BirbeckGL . Migraine: the seventh disabler. Cephalalgia2013;33:289-90.">Steiner 2013</a>). A cross‐sectional survey of eight European Union (EU) countries representing 55% of the adult population estimated the average annual direct and indirect cost per person to be EUR 1222, and a total annual cost for the EU of EUR 111 billion for adults aged 18 to 65 years (<a href="./references#CD002286-bbs2-0035" title="LindeM , GustavssonA , StovnerLJ , SteinerTJ , BarréJ , KatsaravaZ , et al. The cost of headache disorders in Europe: the Eurolight project. European Journal of Neurology2012;19:703-11.">Linde 2012</a>). The economic burden of migraine in the US has been estimated at an average annual direct and indirect cost of USD 1757 for episodic migraine and USD 7750 for chronic migraine per person (<a href="./references#CD002286-bbs2-0037" title="MunakataJ , HazardE , SerranoD , KlingmanD , RupnowMF , TierceJ , et al. Economic burden of transformed migraine: results from the American Migraine Prevalence and Prevention (AMPP) Study. Headache2009;49:498-508.">Munakata 2009</a>). </p> </section> <section id="CD002286-sec-0010"> <h3 class="title" id="CD002286-sec-0010">Description of the intervention</h3> <p>Feverfew (<i>Tanacetum parthenium</i>) is an herbaceous perennial native to Asia Minor and common in the Balkans, now also naturalised throughout most of Europe, the Americas and the rest of the world. It is a member of the Asteraceae family. The dried leaves or aerial parts are used for medicinal purposes. It has traditionally been used for fever, women's ailments, inflammatory conditions, psoriasis, toothache, insect bites, rheumatism, asthma and stomach‐ache. Today feverfew extract is predominantly used for preventing migraine attacks and alleviating accompanying symptoms (<a href="./references#CD002286-bbs2-0022" title="ErnstE , PittlerMH , WiderB , BoddyK . Complementary Therapies for Pain Management. Edinburgh: Elsevier, 2007.">Ernst 2007</a>; <a href="./references#CD002286-bbs2-0039" title="Natural Standard Research Collaboration. Feverfew. Natural Standard, available at www.naturalstandard.com (accessed 4 February 2014).">Natural Standard 2014</a>; <a href="./references#CD002286-bbs2-0041" title="PareekA , SutharM , RathoreGS , BansalV . Feverfew (Tanacetum parthenium) L.): a systematic review. Pharmacognosy Reviews2011;5:103-10.">Pareek 2011</a>). It is available in different forms and preparations such as fresh feverfew leaves, powdered dried feverfew leaves, alcoholic feverfew extracts and CO<sub>2</sub>‐feverfew extract. Concerning the safety of feverfew, toxicity studies have shown that chronic prophylactic use of feverfew does not affect the frequency of chromosomal aberration in lymphocytes or urine mutagenicity (<a href="./references#CD002286-bbs2-0014" title="AndersonD , JenkinsonPC , DewdneyRS , BlowersSD , JohnsonES , KadamNP . Chromosomal aberrations and sister chromatid exchanges in lymphocytes and urine mutagenicity of migraine patients: a comparison of chronic feverfew users and matched non-users. Human Toxicology1988;7:145-52.">Anderson 1988</a>). Anecdotal reports describe contact dermatitis (e.g. <a href="./references#CD002286-bbs2-0019" title="BurryJN . Compositae dermatitis in South Australia: contact dermatitis from Chrysanthemum parthenium. Contact Dermatitis1980;6:445.">Burry 1980</a>; <a href="./references#CD002286-bbs2-0025" title="HausenBM , OsmundsenPE . Contact allergy to parthenolide in Tanacetum parthenium (L.) Schulz-Bip. (feverfew, Asteraceae) and cross-reactions to related sesqiterpene lactone containing Compositae species. Acta Dermato-Venereologica1983;63:308-14.">Hausen 1983</a>). </p> </section> <section id="CD002286-sec-0011"> <h3 class="title" id="CD002286-sec-0011">How the intervention might work</h3> <p>The exact mechanisms of action of feverfew remain unknown. Its anti‐migraine action is probably related to its principally known bioactive ingredient, parthenolide, a sesquiterpene lactone (<a href="./references#CD002286-bbs2-0034" title="KnightDW . Feverfew: Chemistry and biological activity. Natural Product Reports1995;12:271-6.">Knight 1995</a>). Parthenolide comprises up to 85% of the total sesquiterpene content of feverfew and is found in the leaves but not the stems (<a href="./references#CD002286-bbs2-0041" title="PareekA , SutharM , RathoreGS , BansalV . Feverfew (Tanacetum parthenium) L.): a systematic review. Pharmacognosy Reviews2011;5:103-10.">Pareek 2011</a>). Parthenolides probably inhibit prostaglandin production, interfere with both contractile and relaxant mechanisms in blood vessels and perhaps inhibit the secretion of serotonin (5‐HT) (<a href="./references#CD002286-bbs2-0023" title="ESCOP European Scientific Cooperative on Phytotherapy. Tanaceti parthenii herba, feverfew. In: ESCOP Monographs. 2nd edition. Stuttgart: Thieme, 2003.">ESCOP 2003</a>; <a href="./references#CD002286-bbs2-0027" title="HeptinstallS , WhiteA , WilliamsonL , MitchellJRA . Extracts of feverfew inhibit granule secretion in blood platelets and polymorphonuclear leucocytes. Lancet1985;1(8437):1071-4.">Heptinstall 1985</a>; <a href="./references#CD002286-bbs2-0028" title="HeptinstallS , GroenewegenWA , SpangenbergP , LoescheW . Extracts of feverfew may inhibit platelet behaviour via neutralization of sulphydryl groups. Journal of Pharmacy and Pharmacology1987;39:459-65.">Heptinstall 1987</a>; <a href="./references#CD002286-bbs2-0036" title="MakhejaAN , BaileyJM . A platelet phospholipase inhibitor from the medicinal herb feverfew (Tanacetum parthenium). Prostaglandins Leukotrienes and Medicine1982;8:653-60.">Makheja 1982</a>; <a href="./references#CD002286-bbs2-0043" title="PughWJ , SamboK . Prostaglandin synthetase inhibitors in feverfew. Journal of Pharmacy and Pharmacology1988;40:743-5.">Pugh 1988</a>; <a href="./references#CD002286-bbs2-0047" title="TaylorFR . Nutraceuticals and headache: the biological basis. Headache2011;51:484-501.">Taylor 2011</a>). However, one study has suggested only a secondary role for serotonin in the aetiology of migraine (<a href="./references#CD002286-bbs2-0024" title="GoadsbyPJ . How do the currently used prophylactic agents work in migraine?Cephalalgia1997;17:85-92.">Goadsby 1997</a>). Assuming whole‐leaf preparations are effective, this would direct attention more towards other components of the feverfew leaf (<a href="./references#CD002286-bbs2-0015" title="AwangDVC . Prescribing therapeutic feverfew (Tanacetum parthenium (L.) Schultz-Bip., syn. Chrysanthemum parthenium (L.) Bernh.). Integrative Medicine1998;1:11-3.">Awang 1998</a>). This is also suggested by a Dutch study (<a href="./references#CD002286-bbs2-0001" title="deWeerdtCJ , BootsmaHPR , HendriksH . Herbal medicines in migraine prevention: randomized double-blind placebo-controlled crossover trial of a feverfew preparation. Phytomedicine1996;3:225-30. ">de Weerdt 1996</a>), which indicates that the essential oil constituent of feverfew, chrysanthenyl acetate, may be important. This component inhibits prostaglandin synthetase in vitro and seems to possess analgesic properties (<a href="./references#CD002286-bbs2-0043" title="PughWJ , SamboK . Prostaglandin synthetase inhibitors in feverfew. Journal of Pharmacy and Pharmacology1988;40:743-5.">Pugh 1988</a>). Other investigators agree that parthenolide is not the only pharmacologically active constituent in feverfew (<a href="./references#CD002286-bbs2-0017" title="BrownAMG , EdwardsCM , DaveyMR , PowerB , LoweKC . Pharmacological activity of feverfew (Tanacetum parthenium (L.) Schultz-Bip.): assessment by inhibition of human polymorphonuclear leucocyte chemiluminescence in-vitro. Journal of Pharmacy and Pharmacology1997;49:558-61.">Brown 1997</a>; <a href="./references#CD002286-bbs2-0026" title="HendriksH , BosR , WoerdenbagHJ . The essential oil of Tanacetum parthenium (L.) Schultz-Bip. Flavour and Fragrance Journal1996;11:367-71.">Hendriks 1996</a>). A link between the relatively high concentration of melatonin in different feverfew varieties (<a href="./references#CD002286-bbs2-0038" title="MurchSJ , SimmonsCB , SaxenaPK . Melatonin in feverfew and other medicinal plants. Lancet1997;350:1598-9.">Murch 1997</a>) and a decrease in melatonin excretion during migraine attacks has been suggested (<a href="./references#CD002286-bbs2-0018" title="BrunJ , ClaustratB , SaddierP , ChazorG . Nocturnal melatonin excretion is decreased in patients with migraine without aura attacks associated with menses. Cephalalgia1995;15:136-9.">Brun 1995</a>). In conclusion, a definitive chemical link between the aetiology of migraine and parthenolide or any other of the feverfew constituents has still not been established (<a href="./references#CD002286-bbs2-0011" title="KuritzkyA , ElhachamY , YerushalmiZ , HeringR . Feverfew in the treatment of migraine: its effect on serotonin uptake and platelet activity. Neurology1994;44 Suppl 2:A201. ">Kuritzky 1994</a>). </p> <p>As clinical trials of feverfew for the prevention of migraine attacks published in the 1980s and 1990s produced inconsistent results, wide variations in the strength of the parthenolides (<a href="./references#CD002286-bbs2-0051" title="WilligmannJ , FreudensteinJ . Production of a stable feverfew (Tanacetum parthenium) extract as an active substance for a pharmaceutical product. Internal document, Schaper Brummer GmbH and Co., 1999; Poster Symposium. Vienna: Society for Medicinal Plant Research; 1998.">Willigmann 1999</a>) and differences in the stability of feverfew preparations (<a href="./references#CD002286-bbs2-0006" title="PfaffenrathV , DienerHC , FischerM , FriedeM , Henneicke-von ZeppelinHH . The efficacy and safety of Tanacetum parthenium (feverfew) in migraine prophylaxis -- a double-blind, multicentre, randomized placebo-controlled dose-response study. Cephalalgia2002;22:523-32. ">Pfaffenrath 2002</a>) were suggested as explanations. One trial using an extract of feverfew with a standardised and constant concentration of parthenolide to treat migraine did not show any beneficial effect (<a href="./references#CD002286-bbs2-0001" title="deWeerdtCJ , BootsmaHPR , HendriksH . Herbal medicines in migraine prevention: randomized double-blind placebo-controlled crossover trial of a feverfew preparation. Phytomedicine1996;3:225-30. ">de Weerdt 1996</a>). This lack of efficacy might have been due to the absence of essential therapeutic components of the granulated feverfew leaves, which were either not sufficiently extracted, or perhaps degraded during the preparation (<a href="./references#CD002286-bbs2-0001" title="deWeerdtCJ , BootsmaHPR , HendriksH . Herbal medicines in migraine prevention: randomized double-blind placebo-controlled crossover trial of a feverfew preparation. Phytomedicine1996;3:225-30. ">de Weerdt 1996</a>). Subsequently, a new, more stable feverfew extract (MIG‐99) was developed, which was used in the trials by <a href="./references#CD002286-bbs2-0006" title="PfaffenrathV , DienerHC , FischerM , FriedeM , Henneicke-von ZeppelinHH . The efficacy and safety of Tanacetum parthenium (feverfew) in migraine prophylaxis -- a double-blind, multicentre, randomized placebo-controlled dose-response study. Cephalalgia2002;22:523-32. ">Pfaffenrath 2002</a> and <a href="./references#CD002286-bbs2-0002" title="DienerHC , PfaffenrathV , SchnitkerJ , FriedeM , Henneicke-von-Zepelin H-H. Efficacy and safety of 6.25 mg t.i.d. feverfew CO2-extract (MIG-99) in migraine prevention--a randomized, double-blind, multicentre, placebo-controlled study. Cephalalgia2005;25:1031-41. ">Diener 2005</a> but trial results were not fully consistent. </p> </section> <section id="CD002286-sec-0012"> <h3 class="title" id="CD002286-sec-0012">Why it is important to do this review</h3> <p>Some of the existing standard prophylactic treatments, such as propranolol, metoprolol, flunarizine, valproic acid and topiramate, which reduce attack frequency in some patients, are associated with adverse effects (<a href="./references#CD002286-bbs2-0020" title="DodickDW , SilbersteinSD . Migraine prevention. Practical Neurology2007;7:383-93.">Dodick 2007</a>). Furthermore, patients might find long‐term treatment of migraine with drugs unacceptable. An effective, safe and well‐tolerated prophylactic alternative would therefore be desirable. Herbal supplements are very popular and generally available over the counter. Although no specific prevalence data are available for feverfew, a 2013 systematic review of surveys of herbal medicine use in the UK reported a rate of 37.1% across a range of time periods. (<a href="./references#CD002286-bbs2-0042" title="PosadzkiP , WatsonLK , AlotaibiA , ErnstE . Prevalence of herbal medicine use by UK patients/consumers: a systematic review of surveys. Focus on Alternative and Complementary Therapies2013;18:19-26.">Posadzki 2013</a>). Given the high prevalence of use and the demand for non‐drug treatments, it is important to know about the safety and efficacy of herbal products including feverfew. </p> </section> </section> </section> <section class="objectives"> <div class="section-header section-collapse-header" id="CD002286-sec-0013" lang="en"> <h2 class="title section-collapse-title"> Objectives <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="objectives" lang="en"> <div class="section-header" id="CD002286-sec-0013"></div> <p>To systematically review the evidence from double‐blind randomised controlled trials (RCTs) assessing the clinical efficacy and safety of feverfew monopreparations versus placebo for preventing migraine. </p> </section> </section> <section class="methods"> <div class="section-header section-collapse-header" id="CD002286-sec-0014" lang="en"> <h2 class="title section-collapse-title"> Methods <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="methods" lang="en"> <div class="section-header" id="CD002286-sec-0014"></div> <section id="CD002286-sec-0015"> <h3 class="title">Criteria for considering studies for this review</h3> <section id="CD002286-sec-0016"> <h4 class="title">Types of studies</h4> <p>We included placebo‐controlled trials that were both randomised (i.e. trials with a randomised sequence generation and concealed allocation of the sequence) and double‐blind (i.e. trials where neither patients nor care/treatment providers knew whether the patient had received feverfew or placebo). </p> </section> <section id="CD002286-sec-0017"> <h4 class="title">Types of participants</h4> <p>We included studies with participants of all ages suffering from migraine. We did not impose any restrictions in terms of diagnostic criteria; information on the respective diagnostic criteria used in each study is provided in the <a href="./full#CD002286-sec-0036">Results</a> section below, and in the <a href="./references#CD002286-sec-0079" title="">Characteristics of included studies</a> table. </p> </section> <section id="CD002286-sec-0018"> <h4 class="title">Types of interventions</h4> <p>We included trials using oral preparations containing feverfew extract as the only component. We imposed no restrictions regarding dosage. We excluded trials assessing feverfew extract as one of several active components in a combination preparation or as a part of a combination treatment. </p> <p>We considered both treatment studies and withdrawal studies (in which patients already on feverfew medication were randomised to continue on either placebo or feverfew) for inclusion. </p> </section> <section id="CD002286-sec-0019"> <h4 class="title">Types of outcome measures</h4> <p>We included trials using clinical outcome measures, while we excluded trials focusing exclusively on physiological parameters. We collected and analysed trial data on migraine frequency, severity and duration, intensity and severity of nausea and vomiting, global assessment of efficacy, responders (patients with ≥ 50% reduction in headache frequency) and adverse events. We included data reported by participants and study assessors and applied no restrictions in terms of acceptable ways of measuring outcomes. </p> <section id="CD002286-sec-0020"> <h5 class="title">Primary outcomes</h5> <p> <ol id="CD002286-list-0001"> <li> <p>Frequency of migraine attacks</p> </li> </ol> </p> </section> <section id="CD002286-sec-0021"> <h5 class="title">Secondary outcomes</h5> <p> <ol id="CD002286-list-0002"> <li> <p>Intensity and duration of migraine attacks</p> </li> <li> <p>Incidence and severity of nausea/vomiting</p> </li> <li> <p>Global assessment of efficacy</p> </li> <li> <p>Adverse events</p> </li> </ol> </p> </section> </section> </section> <section id="CD002286-sec-0022"> <h3 class="title">Search methods for identification of studies</h3> <p>We ran the search for the original review on 28 July 2003 and ran subsequent searches on 27 January 2009, 12 February 2014 and 27 January 2015. For this update, we contacted manufacturers in February 2014 and performed manual searches in February 2014 and January 2015. </p> <section id="CD002286-sec-0023"> <h4 class="title">Electronic searches</h4> <p>We searched for publications describing randomised, double‐blind trials of feverfew extract for migraine. </p> <p>We performed searches in 2003 and then again in 2009 for past versions of the review in the following databases: </p> <p> <ul id="CD002286-list-0003"> <li> <p>Trials Register of the Cochrane Pain, Palliative and Supportive Care Group (PaPaS) (last searched 27 January 2009); </p> </li> <li> <p>Cochrane Central Register of Controlled Trials (CENTRAL);</p> </li> <li> <p>PREMEDLINE/MEDLINE (from 1966 onwards);</p> </li> <li> <p>EMBASE (from 1974 onwards);</p> </li> <li> <p>Allied and Complementary Medicine Database (AMED) (from 1985 onwards).</p> </li> </ul> </p> <p>For this version of the review, we updated the searches using the following electronic databases: </p> <p> <ul id="CD002286-list-0004"> <li> <p>CENTRAL (2014, Issue 12);</p> </li> <li> <p>MEDLINE (OVID) to 27 January 2015;</p> </li> <li> <p>EMBASE (OVID) to 27 January 2015;</p> </li> <li> <p>AMED (OVID) to 27 January 2015.</p> </li> </ul> </p> <p>The strategies used to search the databases can be found in <a href="./appendices#CD002286-sec-0065">Appendix 1</a>. We applied no filters for randomised controlled trials or controlled clinical trials. </p> <p>We also searched for ongoing trials in the <i>meta</i> Register of Controlled Trials (<i>m</i>RCT) (<a href="http://www.isrctn.com/" target="_blank">http://www.isrctn.com/</a>), ClinicalTrials.gov (<a href="http://www.clinicaltrials.gov" target="_blank">www.clinicaltrials.gov</a>) and the World Health Organization (WHO) International Clinical Trials Registry Platform (ICTRP) (<a href="http://apps.who.int/trialsearch/" target="_blank">http://apps.who.int/trialsearch/</a>), all accessed on 4 February 2015. </p> <section id="CD002286-sec-0024"> <h5 class="title">Language</h5> <p>We imposed no restrictions regarding the language of publication (<a href="./references#CD002286-bbs2-0021" title="EggerM , Zellweger-ZahnerT , SchneiderM , JunkerC , LengelerC , AntesG . Language bias in randomised controlled trials published in English and German. Lancet1997;350:326-9.">Egger 1997</a>). </p> </section> </section> <section id="CD002286-sec-0025"> <h4 class="title">Searching other resources</h4> <section id="CD002286-sec-0026"> <h5 class="title">Handsearching</h5> <p>We performed manual searches using the bibliographies of articles located through the electronic searches and through scanning our own files. </p> </section> <section id="CD002286-sec-0027"> <h5 class="title">Personal contact</h5> <p>We contacted manufacturers of feverfew preparations in February and March 2014 and asked them to contribute relevant published and unpublished material. We received no responses from these manufacturers. </p> </section> </section> </section> <section id="CD002286-sec-0028"> <h3 class="title" id="CD002286-sec-0028">Data collection and analysis</h3> <section id="CD002286-sec-0029"> <h4 class="title">Selection of studies</h4> <p>Two review authors independently screened the retrieved studies for inclusion in the review (BW and MHP for this update, MHP and EE for the previous version of this review). </p> </section> <section id="CD002286-sec-0030"> <h4 class="title">Data extraction and management</h4> <p>Two review authors (BW and MHP for this update, MHP and EE for the previous version of this review) also systematically and independently extracted data from each trial report into a standardised data extraction form. Data extracted included patient characteristics, interventions, methods, outcome measures, efficacy results and adverse events. We resolved disagreements in all aspects of the data extraction and evaluation through discussion between all authors and reached consensus in all cases. </p> </section> <section id="CD002286-sec-0031"> <h4 class="title">Assessment of risk of bias in included studies</h4> <p>We evaluated the methodological quality of the included studies using the Oxford Quality Scale developed by Jadad et al (<a href="./references#CD002286-bbs2-0033" title="JadadAR , MooreRA , CarrolD , JenkinsonC , ReynoldsDJM , GavaghanDJ , et al. Assessing the quality of reports of randomized clinical trials: is blinding necessary?Controlled Clinical Trials1996;17:1-12.">Jadad 1996</a>). This scale quantifies the likelihood of bias inherent in a trial based on the description of randomisation, blinding and withdrawals provided in the trial report. Two review authors (BW and MHP for this update, MHP and EE for the previous version of this review) independently performed the assessment. In addition, we completed Cochrane's 'Risk of bias' table for each study, using assessments of random sequence generation (selection bias), allocation concealment (selection bias), blinding of participants and personnel (performance bias), blinding of outcome assessment (detection bias), incomplete outcome data (attrition bias), selective reporting (reporting bias) and bias due to small sample size. Two authors (BW and MHP) independently assessed all studies and resolved disagreements through discussion. </p> </section> <section id="CD002286-sec-0032"> <h4 class="title">Measures of treatment effect</h4> <p>We used any clinical outcome measures in the efficacy assessment but not solely physiological outcomes. We planned to report standardised mean difference (SMD) for the primary outcome measure but had to abandon this plan due to the heterogeneity of studies. We also listed adverse events for all included studies. </p> </section> <section id="CD002286-sec-0033"> <h4 class="title">Dealing with missing data</h4> <p>If data were missing or inadequate, we contacted the study authors to obtain further details. </p> </section> <section id="CD002286-sec-0034"> <h4 class="title">Assessment of heterogeneity</h4> <p>We planned to assess heterogeneity of efficacy outcomes using the I² statistic (<a href="./references#CD002286-bbs2-0029" title="HigginsJPT , ThompsonSG , DeeksJJ , AltmanDG . Measuring inconsistency in meta-analyses. BMJ2003;327:557-60.">Higgins 2003</a>), but the included studies were too heterogeneous in terms of participants, interventions, methods and outcome measures to be statistically combined. Differences in methods and clinical characteristics are described below in the <a href="#CD002286-sec-0037">Description of studies</a> section. </p> </section> <section id="CD002286-sec-0035"> <h4 class="title">Data synthesis</h4> <p>We considered meta‐analyses of data on the frequency, intensity and duration of migraine attacks, the incidence and severity of nausea/vomiting and the global assessment of efficacy, but abandoned the idea when the scarcity of common outcome measures and differences in methods became apparent. Quantitative data reported for the above outcomes are summarised in the <a href="./full#CD002286-sec-0036">Results</a> section below. </p> </section> </section> </section> </section> <section class="results"> <div class="section-header section-collapse-header" id="CD002286-sec-0036" lang="en"> <h2 class="title section-collapse-title"> Results <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="results" lang="en"> <div class="section-header" id="CD002286-sec-0036"></div> <section id="CD002286-sec-0037"> <h3 class="title">Description of studies</h3> <section id="CD002286-sec-0038"> <h4 class="title">Results of the search</h4> <p>The literature search identified 11 double‐blind RCTs. <a href="#CD002286-fig-0001">Figure 1</a> presents the study flow diagram, which illustrates the study selection procedure. </p> <div class="figure" id="CD002286-fig-0001"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 1</div> </div> <hr class="top"/><img alt="Study flow diagram." data-id="CD002286-fig-0001" src="/cdsr/doi/10.1002/14651858.CD002286.pub3/media/CDSR/CD002286/image_n/nCD002286-FIG-01.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Study flow diagram.</p> </div> </div> </div> <p>See <a href="./references#CD002286-sec-0079" title="">Characteristics of included studies</a> and <a href="./references#CD002286-sec-0080" title="">Characteristics of excluded studies</a>. </p> </section> <section id="CD002286-sec-0039"> <h4 class="title">Included studies</h4> <p>Six trials met the inclusion criteria and we reviewed them for this update. In this version of the review we included one new study (<a href="./references#CD002286-bbs2-0002" title="DienerHC , PfaffenrathV , SchnitkerJ , FriedeM , Henneicke-von-Zepelin H-H. Efficacy and safety of 6.25 mg t.i.d. feverfew CO2-extract (MIG-99) in migraine prevention--a randomized, double-blind, multicentre, placebo-controlled study. Cephalalgia2005;25:1031-41. ">Diener 2005</a>). We identified no relevant unpublished or ongoing trials. </p> <p>In total, 561 patients participated in the included studies. Study sample sizes ranged from 17 to 218. </p> <p>In three studies migraine was diagnosed according to the International Headache Society (IHS) criteria (<a href="./references#CD002286-bbs2-0001" title="deWeerdtCJ , BootsmaHPR , HendriksH . Herbal medicines in migraine prevention: randomized double-blind placebo-controlled crossover trial of a feverfew preparation. Phytomedicine1996;3:225-30. ">de Weerdt 1996</a>; <a href="./references#CD002286-bbs2-0002" title="DienerHC , PfaffenrathV , SchnitkerJ , FriedeM , Henneicke-von-Zepelin H-H. Efficacy and safety of 6.25 mg t.i.d. feverfew CO2-extract (MIG-99) in migraine prevention--a randomized, double-blind, multicentre, placebo-controlled study. Cephalalgia2005;25:1031-41. ">Diener 2005</a>; <a href="./references#CD002286-bbs2-0006" title="PfaffenrathV , DienerHC , FischerM , FriedeM , Henneicke-von ZeppelinHH . The efficacy and safety of Tanacetum parthenium (feverfew) in migraine prophylaxis -- a double-blind, multicentre, randomized placebo-controlled dose-response study. Cephalalgia2002;22:523-32. ">Pfaffenrath 2002</a>), in one according to <a href="./references#CD002286-bbs2-0016" title="BlauJN . Towards a definition of migraine headache. Lancet1984;1:444-5.">Blau 1984</a> (<a href="./references#CD002286-bbs2-0004" title="MurphyJJ , HeptinstallS , MitchellJRA . Randomized double-blind placebo-controlled trial of feverfew in migraine prevention. Lancet1988;2:189-92. ">Murphy 1988</a>), and in two the diagnostic criteria were not specified (<a href="./references#CD002286-bbs2-0003" title="JohnsonES , KadamNP , HylandsDM , HylandsPJ . Efficacy of feverfew as prophylactic treatment of migraine. BMJ1985;291:569-73. ">Johnson 1985</a>; <a href="./references#CD002286-bbs2-0005" title="PalevitchD , EaronG , CarassoR . Feverfew (Tanacetum parthenium) as a prophylactic treatment for migraine: a double-blind placebo-controlled study. Phytotherapy Research1997;11:508-11. ">Palevitch 1997</a>). </p> <p>Three trials were cross‐over trials (<a href="./references#CD002286-bbs2-0001" title="deWeerdtCJ , BootsmaHPR , HendriksH . Herbal medicines in migraine prevention: randomized double-blind placebo-controlled crossover trial of a feverfew preparation. Phytomedicine1996;3:225-30. ">de Weerdt 1996</a>; <a href="./references#CD002286-bbs2-0004" title="MurphyJJ , HeptinstallS , MitchellJRA . Randomized double-blind placebo-controlled trial of feverfew in migraine prevention. Lancet1988;2:189-92. ">Murphy 1988</a>; <a href="./references#CD002286-bbs2-0005" title="PalevitchD , EaronG , CarassoR . Feverfew (Tanacetum parthenium) as a prophylactic treatment for migraine: a double-blind placebo-controlled study. Phytotherapy Research1997;11:508-11. ">Palevitch 1997</a>), and the other three used a parallel‐group design (<a href="./references#CD002286-bbs2-0002" title="DienerHC , PfaffenrathV , SchnitkerJ , FriedeM , Henneicke-von-Zepelin H-H. Efficacy and safety of 6.25 mg t.i.d. feverfew CO2-extract (MIG-99) in migraine prevention--a randomized, double-blind, multicentre, placebo-controlled study. Cephalalgia2005;25:1031-41. ">Diener 2005</a>; <a href="./references#CD002286-bbs2-0003" title="JohnsonES , KadamNP , HylandsDM , HylandsPJ . Efficacy of feverfew as prophylactic treatment of migraine. BMJ1985;291:569-73. ">Johnson 1985</a>; <a href="./references#CD002286-bbs2-0006" title="PfaffenrathV , DienerHC , FischerM , FriedeM , Henneicke-von ZeppelinHH . The efficacy and safety of Tanacetum parthenium (feverfew) in migraine prophylaxis -- a double-blind, multicentre, randomized placebo-controlled dose-response study. Cephalalgia2002;22:523-32. ">Pfaffenrath 2002</a>). Four studies were treatment studies (<a href="./references#CD002286-bbs2-0001" title="deWeerdtCJ , BootsmaHPR , HendriksH . Herbal medicines in migraine prevention: randomized double-blind placebo-controlled crossover trial of a feverfew preparation. Phytomedicine1996;3:225-30. ">de Weerdt 1996</a>; <a href="./references#CD002286-bbs2-0002" title="DienerHC , PfaffenrathV , SchnitkerJ , FriedeM , Henneicke-von-Zepelin H-H. Efficacy and safety of 6.25 mg t.i.d. feverfew CO2-extract (MIG-99) in migraine prevention--a randomized, double-blind, multicentre, placebo-controlled study. Cephalalgia2005;25:1031-41. ">Diener 2005</a>; <a href="./references#CD002286-bbs2-0004" title="MurphyJJ , HeptinstallS , MitchellJRA . Randomized double-blind placebo-controlled trial of feverfew in migraine prevention. Lancet1988;2:189-92. ">Murphy 1988</a>; <a href="./references#CD002286-bbs2-0006" title="PfaffenrathV , DienerHC , FischerM , FriedeM , Henneicke-von ZeppelinHH . The efficacy and safety of Tanacetum parthenium (feverfew) in migraine prophylaxis -- a double-blind, multicentre, randomized placebo-controlled dose-response study. Cephalalgia2002;22:523-32. ">Pfaffenrath 2002</a>), and two were withdrawal studies, i.e. participants already taking feverfew and responding positively to it were randomised to either continue receiving feverfew or to receive a placebo (<a href="./references#CD002286-bbs2-0003" title="JohnsonES , KadamNP , HylandsDM , HylandsPJ . Efficacy of feverfew as prophylactic treatment of migraine. BMJ1985;291:569-73. ">Johnson 1985</a>; <a href="./references#CD002286-bbs2-0005" title="PalevitchD , EaronG , CarassoR . Feverfew (Tanacetum parthenium) as a prophylactic treatment for migraine: a double-blind placebo-controlled study. Phytotherapy Research1997;11:508-11. ">Palevitch 1997</a>). </p> <p>In all studies feverfew was self‐administered orally one to three times daily in capsule form. Three trials administered dried, powdered feverfew extract (<a href="./references#CD002286-bbs2-0003" title="JohnsonES , KadamNP , HylandsDM , HylandsPJ . Efficacy of feverfew as prophylactic treatment of migraine. BMJ1985;291:569-73. ">Johnson 1985</a>; <a href="./references#CD002286-bbs2-0004" title="MurphyJJ , HeptinstallS , MitchellJRA . Randomized double-blind placebo-controlled trial of feverfew in migraine prevention. Lancet1988;2:189-92. ">Murphy 1988</a>; <a href="./references#CD002286-bbs2-0005" title="PalevitchD , EaronG , CarassoR . Feverfew (Tanacetum parthenium) as a prophylactic treatment for migraine: a double-blind placebo-controlled study. Phytotherapy Research1997;11:508-11. ">Palevitch 1997</a>), one used an alcoholic feverfew extract (<a href="./references#CD002286-bbs2-0001" title="deWeerdtCJ , BootsmaHPR , HendriksH . Herbal medicines in migraine prevention: randomized double-blind placebo-controlled crossover trial of a feverfew preparation. Phytomedicine1996;3:225-30. ">de Weerdt 1996</a>), and two used a CO<sub>2</sub>‐extract (<a href="./references#CD002286-bbs2-0002" title="DienerHC , PfaffenrathV , SchnitkerJ , FriedeM , Henneicke-von-Zepelin H-H. Efficacy and safety of 6.25 mg t.i.d. feverfew CO2-extract (MIG-99) in migraine prevention--a randomized, double-blind, multicentre, placebo-controlled study. Cephalalgia2005;25:1031-41. ">Diener 2005</a>; <a href="./references#CD002286-bbs2-0006" title="PfaffenrathV , DienerHC , FischerM , FriedeM , Henneicke-von ZeppelinHH . The efficacy and safety of Tanacetum parthenium (feverfew) in migraine prophylaxis -- a double-blind, multicentre, randomized placebo-controlled dose-response study. Cephalalgia2002;22:523-32. ">Pfaffenrath 2002</a>). Study duration ranged from two to eight months. </p> </section> <section id="CD002286-sec-0040"> <h4 class="title">Excluded studies</h4> <p>For this update, we excluded two trials because they tested combination products (feverfew and ginger, <a href="./references#CD002286-bbs2-0007" title="CadyRK , GoldsteinJ , NettR , MitchellR , BeachME , BrowningR . A double-blind placebo-controlled pilot study of sublingual feverfew and ginger (LipiGesic™ M) in the treatment of migraine. Headache2011;51:1078-86. ">Cady 2011</a>; feverfew with riboflavin and magnesium, <a href="./references#CD002286-bbs2-0012" title="MaizelsM , BlumenfeldA , BurchetterR . A combination of riboflavin, magnesium, and feverfew for migraine prophylaxis: a randomized trial. Headache2004;44:885-90. ">Maizels 2004</a>), one because it did not report on clinical outcomes (<a href="./references#CD002286-bbs2-0011" title="KuritzkyA , ElhachamY , YerushalmiZ , HeringR . Feverfew in the treatment of migraine: its effect on serotonin uptake and platelet activity. Neurology1994;44 Suppl 2:A201. ">Kuritzky 1994</a>), and one because it did not use a placebo comparator (acupuncture versus feverfew versus acupuncture combined with feverfew, <a href="./references#CD002286-bbs2-0008" title="FerroEC , BiaginiAP , da Silva ÍE, SilvaML , SilvaJR . The combined effect of acupuncture and Tanacetum parthenium on quality of life in women with headache: randomised study. Acupuncture in Medicine2012;30:252-7. ">Ferro 2012</a>). </p> <p>We retrieved one ongoing trial through ICTRP. We excluded it because it used a combination product of lavender and feverfew (<a href="./references#CD002286-bbs2-0009" title="RafiS . Investigation of efficacy of feverfew and lavander in migraine prophylaxis. International Clinical Trials Registry Platform. http://www.irct.ir/searchresult.php?id=18776&amp;number=1 , accessed 30 January 2015. ">IRCT2014081218776N1 2015</a>). </p> <p>One trial is available as an abstract only (<a href="./references#CD002286-bbs2-0010" title="KarimooyHN , GholamnezhadZ , TalebiM . Effect of tanacetum parthenium (feverfew) in treatment of migraine headache comparing to dihydroergotamine and placebo. In: Pain Medicine. Vol. 12. 2011:487. ">Karimooy 2011</a>). The abstract does not contain sufficient details to ascertain that the trial meets the inclusion criteria. It is unclear whether the study is randomised and it appears to assess treatment rather than prevention of migraine. Despite contact with the author relevant information about methods and results could not be obtained and we excluded the study. </p> </section> </section> <section id="CD002286-sec-0041"> <h3 class="title">Risk of bias in included studies</h3> <p>We assessed the methodological quality of individual trials using the Oxford Quality Scale devised by Jadad and colleagues (<a href="./references#CD002286-bbs2-0033" title="JadadAR , MooreRA , CarrolD , JenkinsonC , ReynoldsDJM , GavaghanDJ , et al. Assessing the quality of reports of randomized clinical trials: is blinding necessary?Controlled Clinical Trials1996;17:1-12.">Jadad 1996</a>), allocating a total maximum of five points for the following areas: </p> <p>Randomisation (R): Was the study described as randomised? (1 = yes; 0 = no). Was the method of randomisation well described and adequate? (0 = not described; 1 = described and adequate; ‐1 = described, but not adequate). </p> <p>Blinding (B): Was the study described as double‐blind? (1 = yes; 0 = no). Was the method of double‐blinding well described and adequate? (0 = not described; 1 = described and adequate; ‐1 = described, but not adequate). </p> <p>Withdrawals/drop‐outs (W/D): Was there a description of withdrawals and drop‐outs sufficient to determine the number of patients in each treatment group entering and completing the trial? (1 = yes; 0 = no). </p> <p>Five out of the six included studies scored five (<a href="./references#CD002286-bbs2-0001" title="deWeerdtCJ , BootsmaHPR , HendriksH . Herbal medicines in migraine prevention: randomized double-blind placebo-controlled crossover trial of a feverfew preparation. Phytomedicine1996;3:225-30. ">de Weerdt 1996</a>; <a href="./references#CD002286-bbs2-0002" title="DienerHC , PfaffenrathV , SchnitkerJ , FriedeM , Henneicke-von-Zepelin H-H. Efficacy and safety of 6.25 mg t.i.d. feverfew CO2-extract (MIG-99) in migraine prevention--a randomized, double-blind, multicentre, placebo-controlled study. Cephalalgia2005;25:1031-41. ">Diener 2005</a>; <a href="./references#CD002286-bbs2-0006" title="PfaffenrathV , DienerHC , FischerM , FriedeM , Henneicke-von ZeppelinHH . The efficacy and safety of Tanacetum parthenium (feverfew) in migraine prophylaxis -- a double-blind, multicentre, randomized placebo-controlled dose-response study. Cephalalgia2002;22:523-32. ">Pfaffenrath 2002</a>) or four (<a href="./references#CD002286-bbs2-0003" title="JohnsonES , KadamNP , HylandsDM , HylandsPJ . Efficacy of feverfew as prophylactic treatment of migraine. BMJ1985;291:569-73. ">Johnson 1985</a>; <a href="./references#CD002286-bbs2-0004" title="MurphyJJ , HeptinstallS , MitchellJRA . Randomized double-blind placebo-controlled trial of feverfew in migraine prevention. Lancet1988;2:189-92. ">Murphy 1988</a>) points on the Oxford scale used to assess methodological quality (<a href="./references#CD002286-bbs2-0033" title="JadadAR , MooreRA , CarrolD , JenkinsonC , ReynoldsDJM , GavaghanDJ , et al. Assessing the quality of reports of randomized clinical trials: is blinding necessary?Controlled Clinical Trials1996;17:1-12.">Jadad 1996</a>). One study yielded only two points (<a href="./references#CD002286-bbs2-0005" title="PalevitchD , EaronG , CarassoR . Feverfew (Tanacetum parthenium) as a prophylactic treatment for migraine: a double-blind placebo-controlled study. Phytotherapy Research1997;11:508-11. ">Palevitch 1997</a>). The quality scores for each trial are reported in the <a href="./references#CD002286-sec-0079" title="">Characteristics of included studies</a> table. </p> <p>We also assessed risk of bias using the 'Risk of bias' tool (<a href="#CD002286-fig-0002">Figure 2</a>; <a href="#CD002286-fig-0003">Figure 3</a>). </p> <div class="figure" id="CD002286-fig-0002"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 2</div> </div> <hr class="top"/><img alt="'Risk of bias' summary: review authors' judgements about each risk of bias item for each included study." data-id="CD002286-fig-0002" src="/cdsr/doi/10.1002/14651858.CD002286.pub3/media/CDSR/CD002286/image_n/nCD002286-FIG-02.svg"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>'Risk of bias' summary: review authors' judgements about each risk of bias item for each included study. </p> </div> </div> </div> <div class="figure" id="CD002286-fig-0003"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 3</div> </div> <hr class="top"/><img alt="'Risk of bias' graph: review authors' judgements about each risk of bias item presented as percentages across all included studies." data-id="CD002286-fig-0003" src="/cdsr/doi/10.1002/14651858.CD002286.pub3/media/CDSR/CD002286/image_n/nCD002286-FIG-03.svg"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>'Risk of bias' graph: review authors' judgements about each risk of bias item presented as percentages across all included studies. </p> </div> </div> </div> <p>Three studies were of low risk of bias for each risk of bias item (<a href="./references#CD002286-bbs2-0001" title="deWeerdtCJ , BootsmaHPR , HendriksH . Herbal medicines in migraine prevention: randomized double-blind placebo-controlled crossover trial of a feverfew preparation. Phytomedicine1996;3:225-30. ">de Weerdt 1996</a>; <a href="./references#CD002286-bbs2-0002" title="DienerHC , PfaffenrathV , SchnitkerJ , FriedeM , Henneicke-von-Zepelin H-H. Efficacy and safety of 6.25 mg t.i.d. feverfew CO2-extract (MIG-99) in migraine prevention--a randomized, double-blind, multicentre, placebo-controlled study. Cephalalgia2005;25:1031-41. ">Diener 2005</a>; <a href="./references#CD002286-bbs2-0006" title="PfaffenrathV , DienerHC , FischerM , FriedeM , Henneicke-von ZeppelinHH . The efficacy and safety of Tanacetum parthenium (feverfew) in migraine prophylaxis -- a double-blind, multicentre, randomized placebo-controlled dose-response study. Cephalalgia2002;22:523-32. ">Pfaffenrath 2002</a>), and one was of unclear risk or high risk of bias (<a href="./references#CD002286-bbs2-0005" title="PalevitchD , EaronG , CarassoR . Feverfew (Tanacetum parthenium) as a prophylactic treatment for migraine: a double-blind placebo-controlled study. Phytotherapy Research1997;11:508-11. ">Palevitch 1997</a>). The remaining studies were of mixed low and unclear risk (<a href="./references#CD002286-bbs2-0003" title="JohnsonES , KadamNP , HylandsDM , HylandsPJ . Efficacy of feverfew as prophylactic treatment of migraine. BMJ1985;291:569-73. ">Johnson 1985</a>; <a href="./references#CD002286-bbs2-0004" title="MurphyJJ , HeptinstallS , MitchellJRA . Randomized double-blind placebo-controlled trial of feverfew in migraine prevention. Lancet1988;2:189-92. ">Murphy 1988</a>). As per the inclusion criteria, all included studies were randomised and double‐blind. </p> <section id="CD002286-sec-0042"> <h4 class="title">Allocation</h4> <p>As per the inclusion criteria, all included studies were randomised. However, in two studies the random sequence generation was not described (<a href="./references#CD002286-bbs2-0004" title="MurphyJJ , HeptinstallS , MitchellJRA . Randomized double-blind placebo-controlled trial of feverfew in migraine prevention. Lancet1988;2:189-92. ">Murphy 1988</a>; <a href="./references#CD002286-bbs2-0005" title="PalevitchD , EaronG , CarassoR . Feverfew (Tanacetum parthenium) as a prophylactic treatment for migraine: a double-blind placebo-controlled study. Phytotherapy Research1997;11:508-11. ">Palevitch 1997</a>), and three studies did not provide any details of allocation concealment (<a href="./references#CD002286-bbs2-0003" title="JohnsonES , KadamNP , HylandsDM , HylandsPJ . Efficacy of feverfew as prophylactic treatment of migraine. BMJ1985;291:569-73. ">Johnson 1985</a>; <a href="./references#CD002286-bbs2-0004" title="MurphyJJ , HeptinstallS , MitchellJRA . Randomized double-blind placebo-controlled trial of feverfew in migraine prevention. Lancet1988;2:189-92. ">Murphy 1988</a>; <a href="./references#CD002286-bbs2-0005" title="PalevitchD , EaronG , CarassoR . Feverfew (Tanacetum parthenium) as a prophylactic treatment for migraine: a double-blind placebo-controlled study. Phytotherapy Research1997;11:508-11. ">Palevitch 1997</a>). This could be due to reporting flaws rather than actual methodological flaws. </p> </section> <section id="CD002286-sec-0043"> <h4 class="title">Blinding</h4> <p>Two studies provided no further details of blinding such as who was blinded (<a href="./references#CD002286-bbs2-0003" title="JohnsonES , KadamNP , HylandsDM , HylandsPJ . Efficacy of feverfew as prophylactic treatment of migraine. BMJ1985;291:569-73. ">Johnson 1985</a>; <a href="./references#CD002286-bbs2-0005" title="PalevitchD , EaronG , CarassoR . Feverfew (Tanacetum parthenium) as a prophylactic treatment for migraine: a double-blind placebo-controlled study. Phytotherapy Research1997;11:508-11. ">Palevitch 1997</a>). </p> </section> <section id="CD002286-sec-0044"> <h4 class="title">Incomplete outcome data</h4> <p>In two studies the last observation was carried forward if data were missing for subsequent observation periods (<a href="./references#CD002286-bbs2-0002" title="DienerHC , PfaffenrathV , SchnitkerJ , FriedeM , Henneicke-von-Zepelin H-H. Efficacy and safety of 6.25 mg t.i.d. feverfew CO2-extract (MIG-99) in migraine prevention--a randomized, double-blind, multicentre, placebo-controlled study. Cephalalgia2005;25:1031-41. ">Diener 2005</a>; <a href="./references#CD002286-bbs2-0006" title="PfaffenrathV , DienerHC , FischerM , FriedeM , Henneicke-von ZeppelinHH . The efficacy and safety of Tanacetum parthenium (feverfew) in migraine prophylaxis -- a double-blind, multicentre, randomized placebo-controlled dose-response study. Cephalalgia2002;22:523-32. ">Pfaffenrath 2002</a>). In the <a href="./references#CD002286-bbs2-0002" title="DienerHC , PfaffenrathV , SchnitkerJ , FriedeM , Henneicke-von-Zepelin H-H. Efficacy and safety of 6.25 mg t.i.d. feverfew CO2-extract (MIG-99) in migraine prevention--a randomized, double-blind, multicentre, placebo-controlled study. Cephalalgia2005;25:1031-41. ">Diener 2005</a> study, 45 patients had been randomised without fulfilling the IHS criteria and were excluded from the intention‐to‐treat analysis. In two studies the analysis was restricted to participants who completed the study and for whom data were available (<a href="./references#CD002286-bbs2-0001" title="deWeerdtCJ , BootsmaHPR , HendriksH . Herbal medicines in migraine prevention: randomized double-blind placebo-controlled crossover trial of a feverfew preparation. Phytomedicine1996;3:225-30. ">de Weerdt 1996</a>; <a href="./references#CD002286-bbs2-0004" title="MurphyJJ , HeptinstallS , MitchellJRA . Randomized double-blind placebo-controlled trial of feverfew in migraine prevention. Lancet1988;2:189-92. ">Murphy 1988</a>). In one study all participants completed the study and were analysed (<a href="./references#CD002286-bbs2-0003" title="JohnsonES , KadamNP , HylandsDM , HylandsPJ . Efficacy of feverfew as prophylactic treatment of migraine. BMJ1985;291:569-73. ">Johnson 1985</a>). Only one study did not mention drop‐outs and it is unclear whether there were no drop‐outs at all or whether they were not reported (<a href="./references#CD002286-bbs2-0005" title="PalevitchD , EaronG , CarassoR . Feverfew (Tanacetum parthenium) as a prophylactic treatment for migraine: a double-blind placebo-controlled study. Phytotherapy Research1997;11:508-11. ">Palevitch 1997</a>). </p> </section> <section id="CD002286-sec-0045"> <h4 class="title">Selective reporting</h4> <p>Some studies appear at risk of selection bias with non‐reporting of outcomes for some of the clinically relevant and recommended outcome measures in migraine prevention trials (<a href="./references#CD002286-bbs2-0049" title="Tfelt-HansenP , PascualJ , RamadanN , DahlöfC , D'AmicoD , DienerHC , et al, International Headache Society Clinical Trials Subcommittee. Guidelines for controlled trials of drugs in migraine: third edition. A guide for investigators. Cephalalgia2012;32:6-38.">Tfelt‐Hansen 2012</a>): frequency (<a href="./references#CD002286-bbs2-0005" title="PalevitchD , EaronG , CarassoR . Feverfew (Tanacetum parthenium) as a prophylactic treatment for migraine: a double-blind placebo-controlled study. Phytotherapy Research1997;11:508-11. ">Palevitch 1997</a>), duration (<a href="./references#CD002286-bbs2-0001" title="deWeerdtCJ , BootsmaHPR , HendriksH . Herbal medicines in migraine prevention: randomized double-blind placebo-controlled crossover trial of a feverfew preparation. Phytomedicine1996;3:225-30. ">de Weerdt 1996</a>; <a href="./references#CD002286-bbs2-0003" title="JohnsonES , KadamNP , HylandsDM , HylandsPJ . Efficacy of feverfew as prophylactic treatment of migraine. BMJ1985;291:569-73. ">Johnson 1985</a>; <a href="./references#CD002286-bbs2-0005" title="PalevitchD , EaronG , CarassoR . Feverfew (Tanacetum parthenium) as a prophylactic treatment for migraine: a double-blind placebo-controlled study. Phytotherapy Research1997;11:508-11. ">Palevitch 1997</a>), intensity (<a href="./references#CD002286-bbs2-0003" title="JohnsonES , KadamNP , HylandsDM , HylandsPJ . Efficacy of feverfew as prophylactic treatment of migraine. BMJ1985;291:569-73. ">Johnson 1985</a>), or nausea and vomiting (<a href="./references#CD002286-bbs2-0001" title="deWeerdtCJ , BootsmaHPR , HendriksH . Herbal medicines in migraine prevention: randomized double-blind placebo-controlled crossover trial of a feverfew preparation. Phytomedicine1996;3:225-30. ">de Weerdt 1996</a>; <a href="./references#CD002286-bbs2-0002" title="DienerHC , PfaffenrathV , SchnitkerJ , FriedeM , Henneicke-von-Zepelin H-H. Efficacy and safety of 6.25 mg t.i.d. feverfew CO2-extract (MIG-99) in migraine prevention--a randomized, double-blind, multicentre, placebo-controlled study. Cephalalgia2005;25:1031-41. ">Diener 2005</a>). Generally studies reported findings for their respective pre‐defined outcome measures. </p> </section> <section id="CD002286-sec-0046"> <h4 class="title">Other potential sources of bias</h4> <p>All studies were either of unclear (<a href="./references#CD002286-bbs2-0002" title="DienerHC , PfaffenrathV , SchnitkerJ , FriedeM , Henneicke-von-Zepelin H-H. Efficacy and safety of 6.25 mg t.i.d. feverfew CO2-extract (MIG-99) in migraine prevention--a randomized, double-blind, multicentre, placebo-controlled study. Cephalalgia2005;25:1031-41. ">Diener 2005</a>; <a href="./references#CD002286-bbs2-0004" title="MurphyJJ , HeptinstallS , MitchellJRA . Randomized double-blind placebo-controlled trial of feverfew in migraine prevention. Lancet1988;2:189-92. ">Murphy 1988</a>; <a href="./references#CD002286-bbs2-0005" title="PalevitchD , EaronG , CarassoR . Feverfew (Tanacetum parthenium) as a prophylactic treatment for migraine: a double-blind placebo-controlled study. Phytotherapy Research1997;11:508-11. ">Palevitch 1997</a>; <a href="./references#CD002286-bbs2-0006" title="PfaffenrathV , DienerHC , FischerM , FriedeM , Henneicke-von ZeppelinHH . The efficacy and safety of Tanacetum parthenium (feverfew) in migraine prophylaxis -- a double-blind, multicentre, randomized placebo-controlled dose-response study. Cephalalgia2002;22:523-32. ">Pfaffenrath 2002</a>) or high (<a href="./references#CD002286-bbs2-0001" title="deWeerdtCJ , BootsmaHPR , HendriksH . Herbal medicines in migraine prevention: randomized double-blind placebo-controlled crossover trial of a feverfew preparation. Phytomedicine1996;3:225-30. ">de Weerdt 1996</a>; <a href="./references#CD002286-bbs2-0003" title="JohnsonES , KadamNP , HylandsDM , HylandsPJ . Efficacy of feverfew as prophylactic treatment of migraine. BMJ1985;291:569-73. ">Johnson 1985</a>) risk of bias with regards to sample size. </p> </section> </section> <section id="CD002286-sec-0047"> <h3 class="title" id="CD002286-sec-0047">Effects of interventions</h3> <p>As stated in the 'Methods' section above, we did not conduct planned meta‐analyses of data on the frequency, intensity and duration of migraine attacks, the incidence and severity of nausea/vomiting and the global assessment of efficacy due to the lack of common outcome measures and heterogeneity between studies in terms of participants, interventions and designs. The methods and results of each of the six included studies are summarised below to provide an indication of the benefits and harms of feverfew for the prevention of migraine. </p> <section id="CD002286-sec-0048"> <h4 class="title">Efficacy</h4> <p>Johnson et al conducted a study including 17 patients who had taken raw feverfew leaves every day for the previous three to four years (<a href="./references#CD002286-bbs2-0003" title="JohnsonES , KadamNP , HylandsDM , HylandsPJ . Efficacy of feverfew as prophylactic treatment of migraine. BMJ1985;291:569-73. ">Johnson 1985</a>). Patients described as having a history of "common or classical migraine" (diagnostic criteria not specified by the authors) for a duration of at least two years, with eight or fewer attacks per month, were randomised to receive either two capsules of powdered, freeze‐dried feverfew leaves (50 mg total) daily or an identical placebo for 24 weeks. Diary cards were used to assess the frequency of migraine and the incidence of nausea and vomiting. The results showed a significant increase (P value &lt; 0.02) in the number of attacks per month in the placebo group (mean 3.1; standard error (SE) 0.8) compared with baseline, while attack frequency remained constant in patients receiving feverfew (mean 1.7; SE 0.6). Forty‐two per cent and 79% of attacks were associated with nausea and vomiting in the feverfew and placebo groups, respectively (P value &lt; 0.05). The incidence of bouts of nausea/vomiting was significantly lower in the feverfew group (P value &lt; 0.05) than in the placebo group (39 and 116, respectively). The global assessment of efficacy by patients indicated a significant difference (P value &lt; 0.01) in favour of feverfew: six of eight patients in the feverfew group rated the overall treatment effect as moderately good to excellent, while this result was reported by only three of nine patients in the placebo group. Due to the small sample size (n = 17), caution is advised with regards to the reliability and value of the data. </p> <p>Murphy et al randomised 72 patients with common or classical migraine (as defined by <a href="./references#CD002286-bbs2-0016" title="BlauJN . Towards a definition of migraine headache. Lancet1984;1:444-5.">Blau 1984</a>) to receive either one capsule of dried feverfew leaves (mean weight, 82 mg) or placebo for four months after a one‐month placebo run‐in period (<a href="./references#CD002286-bbs2-0004" title="MurphyJJ , HeptinstallS , MitchellJRA . Randomized double-blind placebo-controlled trial of feverfew in migraine prevention. Lancet1988;2:189-92. ">Murphy 1988</a>). Patients were then transferred into the other group for the second four‐month period. There was no wash‐out period between the treatment periods. Outcomes were assessed using a diary of migraine symptoms provided every two months. The results suggested a significant difference (P value &lt; 0.005) in the number of attacks per two‐month period during feverfew treatment (mean 3.6; SE 0.2) compared with placebo (mean 4.7; SE 0.3). Among patients with classical migraine (migraine with aura) (n = 17), the number of attacks per two‐month period was significantly lower (P value &lt; 0.05) with feverfew (mean 2.9; SE 0.4) than with placebo (mean 4.3; SE 0.5); among patients with common migraine (n = 42), headache frequency was similar during the feverfew (mean 3.9; SE 0.3) and placebo (mean 4.9; SE 0.4) periods (P value = 0.06). In the study population as a whole, the total number of attacks rated as severe or very severe was 178/424 (42%) with feverfew and 258/559 (46%) with placebo. Nausea and vomiting accompanied the attacks in 207/424 (49%) and 313/559 (56%) cases treated with feverfew and placebo, respectively (P value &lt; 0.02). The global assessment of efficacy, measured on a 100 mm visual analogue scale with 'worst ever' and 'best ever' as the two extremes, indicated a significant difference (P value &lt; 0.0001) in favour of feverfew compared with placebo (mean 74; SE 2 versus mean 60; SE 3, respectively). Among patients with classical migraine, global assessment scores were significantly higher (P value &lt; 0.01) during treatment with feverfew (mean 78; SE 4) than during treatment with placebo (mean 57; SE 5); among patients with common migraine, scores for the two treatment periods were similar (mean 72; SE 2 for feverfew and mean 61; SE 3 for placebo). </p> <p>De Weerdt et al (<a href="./references#CD002286-bbs2-0001" title="deWeerdtCJ , BootsmaHPR , HendriksH . Herbal medicines in migraine prevention: randomized double-blind placebo-controlled crossover trial of a feverfew preparation. Phytomedicine1996;3:225-30. ">de Weerdt 1996</a>) assessed 50 patients diagnosed according to the criteria of the International Headache Society (<a href="./references#CD002286-bbs2-0030" title="Headache Classification Committee of the International Headache Society. Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain. Cephalalgia1988;8 Suppl 7:1-96.">IHS 1988</a>). Patients suffering from migraine with or without aura received either one capsule of an alcoholic feverfew extract (143 mg) or placebo daily in a randomised cross‐over trial. A one‐month placebo run‐in phase was followed by two two‐month treatment periods. There was no wash‐out period between the treatment periods. The investigators reported that no significant effects on the number or intensity of headaches were observed. Again this study has a small sample size with only 44 patients being included in the final analysis and the results therefore need to be interpreted with caution. </p> <p>The cross‐over trial conducted by Palevitch et al included 57 patients with migraine diagnosed by medical examination (diagnostic criteria not specified) (<a href="./references#CD002286-bbs2-0005" title="PalevitchD , EaronG , CarassoR . Feverfew (Tanacetum parthenium) as a prophylactic treatment for migraine: a double-blind placebo-controlled study. Phytotherapy Research1997;11:508-11. ">Palevitch 1997</a>). Participants as young as nine years old (age range 9 to 65 years) were included despite migraine having different characteristics in young individuals. During the preliminary, open phase of the trial, each patient received 100 mg of powdered, dried feverfew leaves daily for two months. Thereafter, in the double‐blind, cross‐over phase, one group received placebo for 30 days, while the other continued taking feverfew. Patients in the active treatment group were then transferred to the placebo arm and vice versa. There was no wash‐out period between the treatment periods. The intensity of migraine attacks was measured by patients on a numerical scale of 0 ('no pain') to 10 ('most severe pain'), and the severity of nausea and vomiting was assessed using a numerical analogue scale and by questionnaire. The results of the preliminary, open phase showed a significant decrease by 4.27 points on a 10‐point scale in migraine intensity after treatment with feverfew compared with baseline (P value &lt; 0.001). In the first cross‐over phase there was a further reduction of migraine intensity in the feverfew group (mean 1.5; SE 0.7), and an increase in intensity in the placebo group (mean 1.6; SE 0.9) (P value &lt; 0.01). In the second phase of the cross‐over, these trends continued: migraine intensity decreased among patients taking feverfew (mean 4.0; SE 1.1) and increased among patients taking placebo (mean 1.4; SE 1.1). In addition, there was a significant difference (P value &lt; 0.001) in the severity of nausea and vomiting in favour of feverfew. </p> <p>Pfaffenrath et al conducted a double‐blind, placebo‐controlled, multicentre randomised controlled trial (RCT) (<a href="./references#CD002286-bbs2-0006" title="PfaffenrathV , DienerHC , FischerM , FriedeM , Henneicke-von ZeppelinHH . The efficacy and safety of Tanacetum parthenium (feverfew) in migraine prophylaxis -- a double-blind, multicentre, randomized placebo-controlled dose-response study. Cephalalgia2002;22:523-32. ">Pfaffenrath 2002</a>). Three dosage regimens (2.08 mg versus 6.25 mg versus 18.75 mg, each administered three times daily for 12 weeks) of a novel CO<sub>2</sub>‐feverfew extract were compared with placebo. One hundred and forty‐seven patients with migraine with or without aura according to the IHS criteria (<a href="./references#CD002286-bbs2-0030" title="Headache Classification Committee of the International Headache Society. Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain. Cephalalgia1988;8 Suppl 7:1-96.">IHS 1988</a>) were enrolled. The primary endpoint was pre‐defined as the total number of migraine attacks during the last 28 days of treatment compared to the four‐week baseline period. Secondary endpoints included total and average duration and intensity of migraine attacks, number of days with accompanying migraine symptoms and responder rates. There were no statistically significant effects for either primary or secondary outcomes measures. Accordingly, a dose‐response relationship could not be observed. Subgroup analysis including patients with at least four migraine attacks during baseline evaluations (n = 49) showed a significant effect when the 6.25 mg dose was compared with placebo (P value = 0.02). </p> <p><a href="./references#CD002286-bbs2-0002" title="DienerHC , PfaffenrathV , SchnitkerJ , FriedeM , Henneicke-von-Zepelin H-H. Efficacy and safety of 6.25 mg t.i.d. feverfew CO2-extract (MIG-99) in migraine prevention--a randomized, double-blind, multicentre, placebo-controlled study. Cephalalgia2005;25:1031-41. ">Diener 2005</a> conducted a double‐blind, placebo‐controlled, multicentre RCT in patients with a diagnosis of migraine with or without aura according to the IHS criteria (<a href="./references#CD002286-bbs2-0031" title="International Headache Society Clinical Trials Subcommittee. Guidelines for controlled trials of drugs in migraine,second edition. Cephalalgia2000;20:765–86.">IHS 2000</a>). After a four‐week screening period without migraine prophylaxis, 218 participants were randomised to receive either 6.25 mg of a feverfew CO<sub>2</sub>‐extract (MIG‐99, n = 108) or placebo (n = 110) three times daily for 16 weeks. Patients documented each migraine attack in a diary. The primary outcome measure was the total number of migraine attacks within 28 days during the second and third 28‐day treatment period (mean of P2 and P3) compared with baseline (prophylaxis‐free period P0). Secondary efficacy parameters related to frequency, intensity and duration of migraine attacks, clinical global impression of efficacy, medication requirements, number of drop‐outs due to lack of effect of the study medication and responder rate (% of patients with a greater than 50% decrease of migraine attacks per 28 days). Data from 170 patients were available for efficacy analysis in the intention‐to‐treat (ITT) sample (feverfew n = 89, placebo n = 81). The migraine frequency decreased by 1.9 from 4.8 to 2.9 attacks per month in the MIG‐99 group and by 1.3 from 4.8 to 3.5 attacks per month in the placebo group in the weeks 5 to 12 (P value = 0.0456). For the secondary outcome measures, significant differences were reported for responder rates (30.3% in the MIG‐99 group versus 17.3% in the placebo group, P value = 0.047), number of migraine days per 28 days (P value = 0.0353), and global assessment of efficacy by patients (P value = 0.024) and investigators (P value = 0.035). No statistically significant differences were seen for any of the other outcome measures. </p> </section> <section id="CD002286-sec-0049"> <h4 class="title">Adverse events/safety</h4> <p>Five out of the six studies reported on adverse events; only Palevitch did not assess these. The proportion of participants experiencing adverse events varied considerably between studies but there were no statistically significant differences in the occurrence of adverse events between the feverfew and placebo groups. Three studies reported a higher incidence of adverse events during treatment with placebo than with feverfew (<a href="./references#CD002286-bbs2-0002" title="DienerHC , PfaffenrathV , SchnitkerJ , FriedeM , Henneicke-von-Zepelin H-H. Efficacy and safety of 6.25 mg t.i.d. feverfew CO2-extract (MIG-99) in migraine prevention--a randomized, double-blind, multicentre, placebo-controlled study. Cephalalgia2005;25:1031-41. ">Diener 2005</a>; <a href="./references#CD002286-bbs2-0003" title="JohnsonES , KadamNP , HylandsDM , HylandsPJ . Efficacy of feverfew as prophylactic treatment of migraine. BMJ1985;291:569-73. ">Johnson 1985</a>; <a href="./references#CD002286-bbs2-0004" title="MurphyJJ , HeptinstallS , MitchellJRA . Randomized double-blind placebo-controlled trial of feverfew in migraine prevention. Lancet1988;2:189-92. ">Murphy 1988</a>). De Weerdt stated that none of the participants completing the study (one withdrawal) reported adverse events (<a href="./references#CD002286-bbs2-0001" title="deWeerdtCJ , BootsmaHPR , HendriksH . Herbal medicines in migraine prevention: randomized double-blind placebo-controlled crossover trial of a feverfew preparation. Phytomedicine1996;3:225-30. ">de Weerdt 1996</a>). In the <a href="./references#CD002286-bbs2-0002" title="DienerHC , PfaffenrathV , SchnitkerJ , FriedeM , Henneicke-von-Zepelin H-H. Efficacy and safety of 6.25 mg t.i.d. feverfew CO2-extract (MIG-99) in migraine prevention--a randomized, double-blind, multicentre, placebo-controlled study. Cephalalgia2005;25:1031-41. ">Diener 2005</a> study, 8.4% of participants in the feverfew group and 10.2% in the placebo group experienced adverse events. The percentages in the <a href="./references#CD002286-bbs2-0006" title="PfaffenrathV , DienerHC , FischerM , FriedeM , Henneicke-von ZeppelinHH . The efficacy and safety of Tanacetum parthenium (feverfew) in migraine prophylaxis -- a double-blind, multicentre, randomized placebo-controlled dose-response study. Cephalalgia2002;22:523-32. ">Pfaffenrath 2002</a> study were between 12.8% and 30.6% in the high‐dose and low‐dose feverfew groups respectively and 28.6% in the placebo group. In the withdrawal study by <a href="./references#CD002286-bbs2-0003" title="JohnsonES , KadamNP , HylandsDM , HylandsPJ . Efficacy of feverfew as prophylactic treatment of migraine. BMJ1985;291:569-73. ">Johnson 1985</a>, 74% of participants in the feverfew group reported adverse events and 100% in the placebo group (see below). <a href="./references#CD002286-bbs2-0004" title="MurphyJJ , HeptinstallS , MitchellJRA . Randomized double-blind placebo-controlled trial of feverfew in migraine prevention. Lancet1988;2:189-92. ">Murphy 1988</a> did not report numbers of patients experiencing adverse events but reported the incidence of adverse events, which were 28/72 in the feverfew group and 36/72 in the placebo group. </p> <p>Adverse events were generally mild and reversible. Most common were gastrointestinal problems but a wide range of adverse events in the feverfew and placebo groups were reported. <a href="./references#CD002286-bbs2-0003" title="JohnsonES , KadamNP , HylandsDM , HylandsPJ . Efficacy of feverfew as prophylactic treatment of migraine. BMJ1985;291:569-73. ">Johnson 1985</a> reported a high incidence of aches, pains and stiffness in joints and muscles, as well as central nervous system symptoms of nervousness, anxiety and poor sleep (in 13 out of 17 patients) during the placebo phase of their withdrawal study. The authors consider these effects occurring together with a rebound of migraine symptoms to constitute a genuine "post‐feverfew syndrome", which has been reported in long‐term users of feverfew. </p> <p>No serious adverse events related to the study medication occurred in any of the included trials. In total, 13 withdrawals were necessitated by adverse events associated with feverfew, compared with eight withdrawals due to adverse events associated with placebo. Again, adverse events leading to withdrawals were mainly of a gastrointestinal nature. Feverfew did not appear to affect blood pressure, heart rate, body weight or haematological and biochemical safety parameters in any of the included studies. </p> </section> </section> </section> </section> <section class="discussion"> <div class="section-header section-collapse-header" id="CD002286-sec-0050" lang="en"> <h2 class="title section-collapse-title"> Discussion <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="discussion" lang="en"> <div class="section-header" id="CD002286-sec-0050"></div> <section id="CD002286-sec-0051"> <h3 class="title" id="CD002286-sec-0051">Summary of main results</h3> <p>Overall the results from the six included trials are mixed and provide low quality evidence. With the addition of the most recent and largest study, <a href="./references#CD002286-bbs2-0002" title="DienerHC , PfaffenrathV , SchnitkerJ , FriedeM , Henneicke-von-Zepelin H-H. Efficacy and safety of 6.25 mg t.i.d. feverfew CO2-extract (MIG-99) in migraine prevention--a randomized, double-blind, multicentre, placebo-controlled study. Cephalalgia2005;25:1031-41. ">Diener 2005</a>, to this updated Cochrane review, there is evidence from one medium‐sized, rigorous randomised controlled trial (RCT) that feverfew may reduce migraine attacks by 0.6 headaches per month compared to placebo. Results for the secondary outcome measures remain unconvincing. </p> <p>In terms of the main outcome measure, frequency of migraine attacks, statistically significant reductions were reported in two studies (<a href="./references#CD002286-bbs2-0002" title="DienerHC , PfaffenrathV , SchnitkerJ , FriedeM , Henneicke-von-Zepelin H-H. Efficacy and safety of 6.25 mg t.i.d. feverfew CO2-extract (MIG-99) in migraine prevention--a randomized, double-blind, multicentre, placebo-controlled study. Cephalalgia2005;25:1031-41. ">Diener 2005</a>; <a href="./references#CD002286-bbs2-0003" title="JohnsonES , KadamNP , HylandsDM , HylandsPJ . Efficacy of feverfew as prophylactic treatment of migraine. BMJ1985;291:569-73. ">Johnson 1985</a>), as well as in subgroups described by the authors as suffering with classical migraine (with aura) but not common migraine (with aura) (<a href="./references#CD002286-bbs2-0004" title="MurphyJJ , HeptinstallS , MitchellJRA . Randomized double-blind placebo-controlled trial of feverfew in migraine prevention. Lancet1988;2:189-92. ">Murphy 1988</a>), and in the confirmatory subset but not the intention‐to‐treat (ITT) sample in the <a href="./references#CD002286-bbs2-0006" title="PfaffenrathV , DienerHC , FischerM , FriedeM , Henneicke-von ZeppelinHH . The efficacy and safety of Tanacetum parthenium (feverfew) in migraine prophylaxis -- a double-blind, multicentre, randomized placebo-controlled dose-response study. Cephalalgia2002;22:523-32. ">Pfaffenrath 2002</a> study. One study found no differences (<a href="./references#CD002286-bbs2-0001" title="deWeerdtCJ , BootsmaHPR , HendriksH . Herbal medicines in migraine prevention: randomized double-blind placebo-controlled crossover trial of a feverfew preparation. Phytomedicine1996;3:225-30. ">de Weerdt 1996</a>), and one did not report frequency (<a href="./references#CD002286-bbs2-0005" title="PalevitchD , EaronG , CarassoR . Feverfew (Tanacetum parthenium) as a prophylactic treatment for migraine: a double-blind placebo-controlled study. Phytotherapy Research1997;11:508-11. ">Palevitch 1997</a>). </p> <p>Of the five studies assessing intensity of migraine attacks (<a href="./references#CD002286-bbs2-0001" title="deWeerdtCJ , BootsmaHPR , HendriksH . Herbal medicines in migraine prevention: randomized double-blind placebo-controlled crossover trial of a feverfew preparation. Phytomedicine1996;3:225-30. ">de Weerdt 1996</a>; <a href="./references#CD002286-bbs2-0002" title="DienerHC , PfaffenrathV , SchnitkerJ , FriedeM , Henneicke-von-Zepelin H-H. Efficacy and safety of 6.25 mg t.i.d. feverfew CO2-extract (MIG-99) in migraine prevention--a randomized, double-blind, multicentre, placebo-controlled study. Cephalalgia2005;25:1031-41. ">Diener 2005</a>; <a href="./references#CD002286-bbs2-0004" title="MurphyJJ , HeptinstallS , MitchellJRA . Randomized double-blind placebo-controlled trial of feverfew in migraine prevention. Lancet1988;2:189-92. ">Murphy 1988</a>; <a href="./references#CD002286-bbs2-0005" title="PalevitchD , EaronG , CarassoR . Feverfew (Tanacetum parthenium) as a prophylactic treatment for migraine: a double-blind placebo-controlled study. Phytotherapy Research1997;11:508-11. ">Palevitch 1997</a>; <a href="./references#CD002286-bbs2-0006" title="PfaffenrathV , DienerHC , FischerM , FriedeM , Henneicke-von ZeppelinHH . The efficacy and safety of Tanacetum parthenium (feverfew) in migraine prophylaxis -- a double-blind, multicentre, randomized placebo-controlled dose-response study. Cephalalgia2002;22:523-32. ">Pfaffenrath 2002</a>), only <a href="./references#CD002286-bbs2-0005" title="PalevitchD , EaronG , CarassoR . Feverfew (Tanacetum parthenium) as a prophylactic treatment for migraine: a double-blind placebo-controlled study. Phytotherapy Research1997;11:508-11. ">Palevitch 1997</a> reported significant improvements. The three studies that assessed duration of migraine attacks did not report any significant differences between groups (<a href="./references#CD002286-bbs2-0002" title="DienerHC , PfaffenrathV , SchnitkerJ , FriedeM , Henneicke-von-Zepelin H-H. Efficacy and safety of 6.25 mg t.i.d. feverfew CO2-extract (MIG-99) in migraine prevention--a randomized, double-blind, multicentre, placebo-controlled study. Cephalalgia2005;25:1031-41. ">Diener 2005</a>; <a href="./references#CD002286-bbs2-0004" title="MurphyJJ , HeptinstallS , MitchellJRA . Randomized double-blind placebo-controlled trial of feverfew in migraine prevention. Lancet1988;2:189-92. ">Murphy 1988</a>; <a href="./references#CD002286-bbs2-0006" title="PfaffenrathV , DienerHC , FischerM , FriedeM , Henneicke-von ZeppelinHH . The efficacy and safety of Tanacetum parthenium (feverfew) in migraine prophylaxis -- a double-blind, multicentre, randomized placebo-controlled dose-response study. Cephalalgia2002;22:523-32. ">Pfaffenrath 2002</a>). Global assessment was improved in the studies by <a href="./references#CD002286-bbs2-0003" title="JohnsonES , KadamNP , HylandsDM , HylandsPJ . Efficacy of feverfew as prophylactic treatment of migraine. BMJ1985;291:569-73. ">Johnson 1985</a> and <a href="./references#CD002286-bbs2-0002" title="DienerHC , PfaffenrathV , SchnitkerJ , FriedeM , Henneicke-von-Zepelin H-H. Efficacy and safety of 6.25 mg t.i.d. feverfew CO2-extract (MIG-99) in migraine prevention--a randomized, double-blind, multicentre, placebo-controlled study. Cephalalgia2005;25:1031-41. ">Diener 2005</a>, as well as in the subgroup with classical migraine (with aura) in the study by <a href="./references#CD002286-bbs2-0004" title="MurphyJJ , HeptinstallS , MitchellJRA . Randomized double-blind placebo-controlled trial of feverfew in migraine prevention. Lancet1988;2:189-92. ">Murphy 1988</a> (not assessed/reported in the other studies). The incidence of nausea and vomiting was reduced in the studies by <a href="./references#CD002286-bbs2-0003" title="JohnsonES , KadamNP , HylandsDM , HylandsPJ . Efficacy of feverfew as prophylactic treatment of migraine. BMJ1985;291:569-73. ">Johnson 1985</a>, <a href="./references#CD002286-bbs2-0004" title="MurphyJJ , HeptinstallS , MitchellJRA . Randomized double-blind placebo-controlled trial of feverfew in migraine prevention. Lancet1988;2:189-92. ">Murphy 1988</a> and <a href="./references#CD002286-bbs2-0005" title="PalevitchD , EaronG , CarassoR . Feverfew (Tanacetum parthenium) as a prophylactic treatment for migraine: a double-blind placebo-controlled study. Phytotherapy Research1997;11:508-11. ">Palevitch 1997</a>, while <a href="./references#CD002286-bbs2-0006" title="PfaffenrathV , DienerHC , FischerM , FriedeM , Henneicke-von ZeppelinHH . The efficacy and safety of Tanacetum parthenium (feverfew) in migraine prophylaxis -- a double-blind, multicentre, randomized placebo-controlled dose-response study. Cephalalgia2002;22:523-32. ">Pfaffenrath 2002</a> did not observe any differences. </p> <p>Two of the three trials at low risk of bias did not report statistically significant improvements for any outcomes in their main analysis (<a href="./references#CD002286-bbs2-0001" title="deWeerdtCJ , BootsmaHPR , HendriksH . Herbal medicines in migraine prevention: randomized double-blind placebo-controlled crossover trial of a feverfew preparation. Phytomedicine1996;3:225-30. ">de Weerdt 1996</a>; <a href="./references#CD002286-bbs2-0006" title="PfaffenrathV , DienerHC , FischerM , FriedeM , Henneicke-von ZeppelinHH . The efficacy and safety of Tanacetum parthenium (feverfew) in migraine prophylaxis -- a double-blind, multicentre, randomized placebo-controlled dose-response study. Cephalalgia2002;22:523-32. ">Pfaffenrath 2002</a>), while only one did (<a href="./references#CD002286-bbs2-0002" title="DienerHC , PfaffenrathV , SchnitkerJ , FriedeM , Henneicke-von-Zepelin H-H. Efficacy and safety of 6.25 mg t.i.d. feverfew CO2-extract (MIG-99) in migraine prevention--a randomized, double-blind, multicentre, placebo-controlled study. Cephalalgia2005;25:1031-41. ">Diener 2005</a>). The two studies reporting positive results for all pre‐defined outcome measures were both withdrawal studies (<a href="./references#CD002286-bbs2-0003" title="JohnsonES , KadamNP , HylandsDM , HylandsPJ . Efficacy of feverfew as prophylactic treatment of migraine. BMJ1985;291:569-73. ">Johnson 1985</a>; <a href="./references#CD002286-bbs2-0005" title="PalevitchD , EaronG , CarassoR . Feverfew (Tanacetum parthenium) as a prophylactic treatment for migraine: a double-blind placebo-controlled study. Phytotherapy Research1997;11:508-11. ">Palevitch 1997</a>); the first is limited by a small number of participants (n = 17) (<a href="./references#CD002286-bbs2-0048" title="Tfelt-HansenP , NielsenSL . Patient numbers needed in prophylactic migraine trials. Neuroepidemiology1987;6:214-9.">Tfelt‐Hansen 1987</a>), and the latter was of unclear/high risk of bias and scored only two points on the Oxford Quality Scale. Generally the studies are of small sample size with four studies including fewer than 100 participants (<a href="./references#CD002286-bbs2-0001" title="deWeerdtCJ , BootsmaHPR , HendriksH . Herbal medicines in migraine prevention: randomized double-blind placebo-controlled crossover trial of a feverfew preparation. Phytomedicine1996;3:225-30. ">de Weerdt 1996</a>; <a href="./references#CD002286-bbs2-0003" title="JohnsonES , KadamNP , HylandsDM , HylandsPJ . Efficacy of feverfew as prophylactic treatment of migraine. BMJ1985;291:569-73. ">Johnson 1985</a>; <a href="./references#CD002286-bbs2-0004" title="MurphyJJ , HeptinstallS , MitchellJRA . Randomized double-blind placebo-controlled trial of feverfew in migraine prevention. Lancet1988;2:189-92. ">Murphy 1988</a>; <a href="./references#CD002286-bbs2-0005" title="PalevitchD , EaronG , CarassoR . Feverfew (Tanacetum parthenium) as a prophylactic treatment for migraine: a double-blind placebo-controlled study. Phytotherapy Research1997;11:508-11. ">Palevitch 1997</a>). </p> <p>In the included trials the adverse events reported were generally mild and reversible. Mouth ulceration and gastrointestinal symptoms were reported most frequently and were also experienced by long‐time feverfew users. Such problems can be avoided through the use of more carefully prepared formulations of feverfew. A post‐feverfew syndrome was reported by long‐time feverfew consumers after discontinuation of feverfew intake (<a href="./references#CD002286-bbs2-0003" title="JohnsonES , KadamNP , HylandsDM , HylandsPJ . Efficacy of feverfew as prophylactic treatment of migraine. BMJ1985;291:569-73. ">Johnson 1985</a>). Collectively these data imply that oral feverfew medication is relatively safe. However, more information is needed to detect serious or rare adverse events, and on long‐term clinical use. </p> </section> <section id="CD002286-sec-0052"> <h3 class="title" id="CD002286-sec-0052">Overall completeness and applicability of evidence</h3> <p>There is considerable variation in the six included trials of 561 participants in terms of designs, participants, interventions and outcome measures, which might explain the inconsistent results. This variation makes it difficult to apply these findings to the general population. </p> <section id="CD002286-sec-0053"> <h4 class="title">Participants</h4> <p>In terms of participants, the diagnostic criteria varied. While three studies used the International Headache Society (IHS) criteria (<a href="./references#CD002286-bbs2-0001" title="deWeerdtCJ , BootsmaHPR , HendriksH . Herbal medicines in migraine prevention: randomized double-blind placebo-controlled crossover trial of a feverfew preparation. Phytomedicine1996;3:225-30. ">de Weerdt 1996</a>; <a href="./references#CD002286-bbs2-0002" title="DienerHC , PfaffenrathV , SchnitkerJ , FriedeM , Henneicke-von-Zepelin H-H. Efficacy and safety of 6.25 mg t.i.d. feverfew CO2-extract (MIG-99) in migraine prevention--a randomized, double-blind, multicentre, placebo-controlled study. Cephalalgia2005;25:1031-41. ">Diener 2005</a>; <a href="./references#CD002286-bbs2-0006" title="PfaffenrathV , DienerHC , FischerM , FriedeM , Henneicke-von ZeppelinHH . The efficacy and safety of Tanacetum parthenium (feverfew) in migraine prophylaxis -- a double-blind, multicentre, randomized placebo-controlled dose-response study. Cephalalgia2002;22:523-32. ">Pfaffenrath 2002</a>), one used Blau (<a href="./references#CD002286-bbs2-0004" title="MurphyJJ , HeptinstallS , MitchellJRA . Randomized double-blind placebo-controlled trial of feverfew in migraine prevention. Lancet1988;2:189-92. ">Murphy 1988</a>), and two did not specify the criteria used (<a href="./references#CD002286-bbs2-0003" title="JohnsonES , KadamNP , HylandsDM , HylandsPJ . Efficacy of feverfew as prophylactic treatment of migraine. BMJ1985;291:569-73. ">Johnson 1985</a>; <a href="./references#CD002286-bbs2-0005" title="PalevitchD , EaronG , CarassoR . Feverfew (Tanacetum parthenium) as a prophylactic treatment for migraine: a double-blind placebo-controlled study. Phytotherapy Research1997;11:508-11. ">Palevitch 1997</a>). In some studies participants were feverfew‐naive (<a href="./references#CD002286-bbs2-0001" title="deWeerdtCJ , BootsmaHPR , HendriksH . Herbal medicines in migraine prevention: randomized double-blind placebo-controlled crossover trial of a feverfew preparation. Phytomedicine1996;3:225-30. ">de Weerdt 1996</a>; <a href="./references#CD002286-bbs2-0005" title="PalevitchD , EaronG , CarassoR . Feverfew (Tanacetum parthenium) as a prophylactic treatment for migraine: a double-blind placebo-controlled study. Phytotherapy Research1997;11:508-11. ">Palevitch 1997</a>), while in the study by <a href="./references#CD002286-bbs2-0003" title="JohnsonES , KadamNP , HylandsDM , HylandsPJ . Efficacy of feverfew as prophylactic treatment of migraine. BMJ1985;291:569-73. ">Johnson 1985</a> feverfew consumption for the last three to four years was an inclusion criterion. <a href="./references#CD002286-bbs2-0005" title="PalevitchD , EaronG , CarassoR . Feverfew (Tanacetum parthenium) as a prophylactic treatment for migraine: a double-blind placebo-controlled study. Phytotherapy Research1997;11:508-11. ">Palevitch 1997</a> included participants as young as nine years old (age range 9 to 65 years) despite migraine having different characteristics in young individuals. </p> </section> <section id="CD002286-sec-0054"> <h4 class="title">Design</h4> <p>Most studies had small numbers of participants, particularly in the subgroups. The sample size of studies ranged between 17 and 218; four trials had 72 or fewer participants and one thereof (n = 17) had fewer than 10 patients per treatment group (<a href="./references#CD002286-bbs2-0003" title="JohnsonES , KadamNP , HylandsDM , HylandsPJ . Efficacy of feverfew as prophylactic treatment of migraine. BMJ1985;291:569-73. ">Johnson 1985</a>), which has an influence on effect sizes. Their statistical analyses therefore need to be interpreted with caution. Small sample size can expose studies to the hazards of random chance; at the same time studies with small sample sizes are more likely to overestimate results (<a href="./references#CD002286-bbs2-0040" title="NüeschE , TrelleS , ReichenbachS , RutjesAW , TschannenB , AltmanDG , et al. Small study effects in meta-analyses of osteoarthritis trials: meta-epidemiological study. BMJ2010;16:c3515.">Nüesch 2010</a>). </p> <p>The trials included treatment and withdrawal studies as well as parallel‐group and cross‐over studies. In order to reduce carry‐over effects the IHS recommends a wash‐out phase of at least one month. The two parallel‐group treatment studies by <a href="./references#CD002286-bbs2-0006" title="PfaffenrathV , DienerHC , FischerM , FriedeM , Henneicke-von ZeppelinHH . The efficacy and safety of Tanacetum parthenium (feverfew) in migraine prophylaxis -- a double-blind, multicentre, randomized placebo-controlled dose-response study. Cephalalgia2002;22:523-32. ">Pfaffenrath 2002</a> and <a href="./references#CD002286-bbs2-0002" title="DienerHC , PfaffenrathV , SchnitkerJ , FriedeM , Henneicke-von-Zepelin H-H. Efficacy and safety of 6.25 mg t.i.d. feverfew CO2-extract (MIG-99) in migraine prevention--a randomized, double-blind, multicentre, placebo-controlled study. Cephalalgia2005;25:1031-41. ">Diener 2005</a> used a treatment‐free/placebo run‐in phase before the start of the trial. </p> <p>Particularly in cross‐over trials carry‐over effects can present a significant problem. The effects of feverfew given in the first period might persist into the subsequent placebo period (or vice versa), thus interfering with the effects of the subsequent intervention. However, none of the three cross‐over studies used wash‐out phases between the two intervention phases. Two of them included a one‐month run‐in phase but no wash‐out before cross‐over (<a href="./references#CD002286-bbs2-0001" title="deWeerdtCJ , BootsmaHPR , HendriksH . Herbal medicines in migraine prevention: randomized double-blind placebo-controlled crossover trial of a feverfew preparation. Phytomedicine1996;3:225-30. ">de Weerdt 1996</a>; <a href="./references#CD002286-bbs2-0004" title="MurphyJJ , HeptinstallS , MitchellJRA . Randomized double-blind placebo-controlled trial of feverfew in migraine prevention. Lancet1988;2:189-92. ">Murphy 1988</a>), and one did not employ any wash‐out phase (<a href="./references#CD002286-bbs2-0005" title="PalevitchD , EaronG , CarassoR . Feverfew (Tanacetum parthenium) as a prophylactic treatment for migraine: a double-blind placebo-controlled study. Phytotherapy Research1997;11:508-11. ">Palevitch 1997</a>). <a href="./references#CD002286-bbs2-0004" title="MurphyJJ , HeptinstallS , MitchellJRA . Randomized double-blind placebo-controlled trial of feverfew in migraine prevention. Lancet1988;2:189-92. ">Murphy 1988</a> discussed the possibility of a carry‐over effect but concluded that their data did not support this. <a href="./references#CD002286-bbs2-0001" title="deWeerdtCJ , BootsmaHPR , HendriksH . Herbal medicines in migraine prevention: randomized double-blind placebo-controlled crossover trial of a feverfew preparation. Phytomedicine1996;3:225-30. ">de Weerdt 1996</a> states that the average response to the two treatments was the same regardless of the order in which they were received. Similarly, no taper was used in the withdrawal studies to reduce the risk of a 'post‐feverfew syndrome', which has been described in long‐term users who abruptly discontinue use of feverfew (<a href="./references#CD002286-bbs2-0006" title="PfaffenrathV , DienerHC , FischerM , FriedeM , Henneicke-von ZeppelinHH . The efficacy and safety of Tanacetum parthenium (feverfew) in migraine prophylaxis -- a double-blind, multicentre, randomized placebo-controlled dose-response study. Cephalalgia2002;22:523-32. ">Pfaffenrath 2002</a>). Post‐feverfew syndrome includes among others a rebound of migraine symptoms, which is consistent with the results in the two withdrawal studies by <a href="./references#CD002286-bbs2-0005" title="PalevitchD , EaronG , CarassoR . Feverfew (Tanacetum parthenium) as a prophylactic treatment for migraine: a double-blind placebo-controlled study. Phytotherapy Research1997;11:508-11. ">Palevitch 1997</a> and <a href="./references#CD002286-bbs2-0003" title="JohnsonES , KadamNP , HylandsDM , HylandsPJ . Efficacy of feverfew as prophylactic treatment of migraine. BMJ1985;291:569-73. ">Johnson 1985</a>. Treatment periods ranged from 60 days (<a href="./references#CD002286-bbs2-0005" title="PalevitchD , EaronG , CarassoR . Feverfew (Tanacetum parthenium) as a prophylactic treatment for migraine: a double-blind placebo-controlled study. Phytotherapy Research1997;11:508-11. ">Palevitch 1997</a>) to nine months (<a href="./references#CD002286-bbs2-0001" title="deWeerdtCJ , BootsmaHPR , HendriksH . Herbal medicines in migraine prevention: randomized double-blind placebo-controlled crossover trial of a feverfew preparation. Phytomedicine1996;3:225-30. ">de Weerdt 1996</a>). The IHS recommends at least three months for phase II trials. </p> </section> <section id="CD002286-sec-0055"> <h4 class="title">Intervention</h4> <p>Different types of medication were used in the studies: three trials administered dried, powdered feverfew extract (<a href="./references#CD002286-bbs2-0003" title="JohnsonES , KadamNP , HylandsDM , HylandsPJ . Efficacy of feverfew as prophylactic treatment of migraine. BMJ1985;291:569-73. ">Johnson 1985</a>; <a href="./references#CD002286-bbs2-0004" title="MurphyJJ , HeptinstallS , MitchellJRA . Randomized double-blind placebo-controlled trial of feverfew in migraine prevention. Lancet1988;2:189-92. ">Murphy 1988</a>; <a href="./references#CD002286-bbs2-0005" title="PalevitchD , EaronG , CarassoR . Feverfew (Tanacetum parthenium) as a prophylactic treatment for migraine: a double-blind placebo-controlled study. Phytotherapy Research1997;11:508-11. ">Palevitch 1997</a>), one used an alcoholic feverfew extract (<a href="./references#CD002286-bbs2-0001" title="deWeerdtCJ , BootsmaHPR , HendriksH . Herbal medicines in migraine prevention: randomized double-blind placebo-controlled crossover trial of a feverfew preparation. Phytomedicine1996;3:225-30. ">de Weerdt 1996</a>), and two used a CO<sub>2</sub>‐extract (<a href="./references#CD002286-bbs2-0002" title="DienerHC , PfaffenrathV , SchnitkerJ , FriedeM , Henneicke-von-Zepelin H-H. Efficacy and safety of 6.25 mg t.i.d. feverfew CO2-extract (MIG-99) in migraine prevention--a randomized, double-blind, multicentre, placebo-controlled study. Cephalalgia2005;25:1031-41. ">Diener 2005</a>; <a href="./references#CD002286-bbs2-0006" title="PfaffenrathV , DienerHC , FischerM , FriedeM , Henneicke-von ZeppelinHH . The efficacy and safety of Tanacetum parthenium (feverfew) in migraine prophylaxis -- a double-blind, multicentre, randomized placebo-controlled dose-response study. Cephalalgia2002;22:523-32. ">Pfaffenrath 2002</a>). In these two most recent trials care was given to using a stable extract of feverfew highly enriched with parthenolide. Furthermore the most recent trial by <a href="./references#CD002286-bbs2-0002" title="DienerHC , PfaffenrathV , SchnitkerJ , FriedeM , Henneicke-von-Zepelin H-H. Efficacy and safety of 6.25 mg t.i.d. feverfew CO2-extract (MIG-99) in migraine prevention--a randomized, double-blind, multicentre, placebo-controlled study. Cephalalgia2005;25:1031-41. ">Diener 2005</a> used a dosage of 6.25 mg three times a day, which had shown the most promising results in the earlier dose‐finding study by the same author team (<a href="./references#CD002286-bbs2-0006" title="PfaffenrathV , DienerHC , FischerM , FriedeM , Henneicke-von ZeppelinHH . The efficacy and safety of Tanacetum parthenium (feverfew) in migraine prophylaxis -- a double-blind, multicentre, randomized placebo-controlled dose-response study. Cephalalgia2002;22:523-32. ">Pfaffenrath 2002</a>), </p> <p>Patients were asked to stop any other medication for migraine prevention but use of analgesics to treat acute attacks was allowed and reported in four studies (<a href="./references#CD002286-bbs2-0001" title="deWeerdtCJ , BootsmaHPR , HendriksH . Herbal medicines in migraine prevention: randomized double-blind placebo-controlled crossover trial of a feverfew preparation. Phytomedicine1996;3:225-30. ">de Weerdt 1996</a>; <a href="./references#CD002286-bbs2-0002" title="DienerHC , PfaffenrathV , SchnitkerJ , FriedeM , Henneicke-von-Zepelin H-H. Efficacy and safety of 6.25 mg t.i.d. feverfew CO2-extract (MIG-99) in migraine prevention--a randomized, double-blind, multicentre, placebo-controlled study. Cephalalgia2005;25:1031-41. ">Diener 2005</a>; <a href="./references#CD002286-bbs2-0003" title="JohnsonES , KadamNP , HylandsDM , HylandsPJ . Efficacy of feverfew as prophylactic treatment of migraine. BMJ1985;291:569-73. ">Johnson 1985</a>; <a href="./references#CD002286-bbs2-0006" title="PfaffenrathV , DienerHC , FischerM , FriedeM , Henneicke-von ZeppelinHH . The efficacy and safety of Tanacetum parthenium (feverfew) in migraine prophylaxis -- a double-blind, multicentre, randomized placebo-controlled dose-response study. Cephalalgia2002;22:523-32. ">Pfaffenrath 2002</a>). Higher consumption of analgesics in the placebo groups was reported by two studies (<a href="./references#CD002286-bbs2-0001" title="deWeerdtCJ , BootsmaHPR , HendriksH . Herbal medicines in migraine prevention: randomized double-blind placebo-controlled crossover trial of a feverfew preparation. Phytomedicine1996;3:225-30. ">de Weerdt 1996</a>; <a href="./references#CD002286-bbs2-0003" title="JohnsonES , KadamNP , HylandsDM , HylandsPJ . Efficacy of feverfew as prophylactic treatment of migraine. BMJ1985;291:569-73. ">Johnson 1985</a>), one study found no differences between groups (<a href="./references#CD002286-bbs2-0006" title="PfaffenrathV , DienerHC , FischerM , FriedeM , Henneicke-von ZeppelinHH . The efficacy and safety of Tanacetum parthenium (feverfew) in migraine prophylaxis -- a double-blind, multicentre, randomized placebo-controlled dose-response study. Cephalalgia2002;22:523-32. ">Pfaffenrath 2002</a>) and one did not report any results (<a href="./references#CD002286-bbs2-0002" title="DienerHC , PfaffenrathV , SchnitkerJ , FriedeM , Henneicke-von-Zepelin H-H. Efficacy and safety of 6.25 mg t.i.d. feverfew CO2-extract (MIG-99) in migraine prevention--a randomized, double-blind, multicentre, placebo-controlled study. Cephalalgia2005;25:1031-41. ">Diener 2005</a>). One study did not record concomitant medication (<a href="./references#CD002286-bbs2-0005" title="PalevitchD , EaronG , CarassoR . Feverfew (Tanacetum parthenium) as a prophylactic treatment for migraine: a double-blind placebo-controlled study. Phytotherapy Research1997;11:508-11. ">Palevitch 1997</a>) and one stated that all migraine medication was stopped but did not specify whether analgesics were allowed as rescue medication (<a href="./references#CD002286-bbs2-0004" title="MurphyJJ , HeptinstallS , MitchellJRA . Randomized double-blind placebo-controlled trial of feverfew in migraine prevention. Lancet1988;2:189-92. ">Murphy 1988</a>). It is unlikely that the use of analgesics to treat acute attacks will have influenced the results for the incidence of migraine attacks. </p> </section> <section id="CD002286-sec-0056"> <h4 class="title">Evaluation/outcome measures</h4> <p>Generally the trials used headache diaries to record a variety of outcomes. Although frequency, duration and intensity of migraine attacks, as well as incidence and severity of nausea and vomiting, were the most commonly used outcome measures, the individual studies varied in the outcome measures used and some did not report results for frequency (<a href="./references#CD002286-bbs2-0005" title="PalevitchD , EaronG , CarassoR . Feverfew (Tanacetum parthenium) as a prophylactic treatment for migraine: a double-blind placebo-controlled study. Phytotherapy Research1997;11:508-11. ">Palevitch 1997</a>), duration (<a href="./references#CD002286-bbs2-0001" title="deWeerdtCJ , BootsmaHPR , HendriksH . Herbal medicines in migraine prevention: randomized double-blind placebo-controlled crossover trial of a feverfew preparation. Phytomedicine1996;3:225-30. ">de Weerdt 1996</a>; <a href="./references#CD002286-bbs2-0003" title="JohnsonES , KadamNP , HylandsDM , HylandsPJ . Efficacy of feverfew as prophylactic treatment of migraine. BMJ1985;291:569-73. ">Johnson 1985</a>; <a href="./references#CD002286-bbs2-0005" title="PalevitchD , EaronG , CarassoR . Feverfew (Tanacetum parthenium) as a prophylactic treatment for migraine: a double-blind placebo-controlled study. Phytotherapy Research1997;11:508-11. ">Palevitch 1997</a>), intensity (<a href="./references#CD002286-bbs2-0003" title="JohnsonES , KadamNP , HylandsDM , HylandsPJ . Efficacy of feverfew as prophylactic treatment of migraine. BMJ1985;291:569-73. ">Johnson 1985</a>), or nausea and vomiting (<a href="./references#CD002286-bbs2-0001" title="deWeerdtCJ , BootsmaHPR , HendriksH . Herbal medicines in migraine prevention: randomized double-blind placebo-controlled crossover trial of a feverfew preparation. Phytomedicine1996;3:225-30. ">de Weerdt 1996</a>; <a href="./references#CD002286-bbs2-0002" title="DienerHC , PfaffenrathV , SchnitkerJ , FriedeM , Henneicke-von-Zepelin H-H. Efficacy and safety of 6.25 mg t.i.d. feverfew CO2-extract (MIG-99) in migraine prevention--a randomized, double-blind, multicentre, placebo-controlled study. Cephalalgia2005;25:1031-41. ">Diener 2005</a>). Migraine attacks were reported differently (e.g. as migraine days, migraine attacks, days with a certain attack intensity, use of analgesics, etc.) and over a range of time frames (e.g. last four weeks of the trial period, over total trial duration). They were also presented differently (values at a certain time interval with or without measures of variance, per cent change compared to baseline, etc.). </p> </section> </section> <section id="CD002286-sec-0057"> <h3 class="title" id="CD002286-sec-0057">Quality of the evidence</h3> <p>Generally the quality of the evidence was good with five studies being of low risk of bias for most criteria and scoring four to five points on the Oxford scale. Only one study scored only two points on the Oxford scale and we considered it of unclear risk of bias for all criteria (<a href="./references#CD002286-bbs2-0005" title="PalevitchD , EaronG , CarassoR . Feverfew (Tanacetum parthenium) as a prophylactic treatment for migraine: a double-blind placebo-controlled study. Phytotherapy Research1997;11:508-11. ">Palevitch 1997</a>). However, four out of the six studies had fewer than 100 participants; two studies are of high risk of bias due to small sample size (<a href="./references#CD002286-bbs2-0001" title="deWeerdtCJ , BootsmaHPR , HendriksH . Herbal medicines in migraine prevention: randomized double-blind placebo-controlled crossover trial of a feverfew preparation. Phytomedicine1996;3:225-30. ">de Weerdt 1996</a>; <a href="./references#CD002286-bbs2-0003" title="JohnsonES , KadamNP , HylandsDM , HylandsPJ . Efficacy of feverfew as prophylactic treatment of migraine. BMJ1985;291:569-73. ">Johnson 1985</a>), the others are of unclear risk of bias. Their results therefore need to be interpreted with caution. The two latest and largest trials, <a href="./references#CD002286-bbs2-0002" title="DienerHC , PfaffenrathV , SchnitkerJ , FriedeM , Henneicke-von-Zepelin H-H. Efficacy and safety of 6.25 mg t.i.d. feverfew CO2-extract (MIG-99) in migraine prevention--a randomized, double-blind, multicentre, placebo-controlled study. Cephalalgia2005;25:1031-41. ">Diener 2005</a> and <a href="./references#CD002286-bbs2-0006" title="PfaffenrathV , DienerHC , FischerM , FriedeM , Henneicke-von ZeppelinHH . The efficacy and safety of Tanacetum parthenium (feverfew) in migraine prophylaxis -- a double-blind, multicentre, randomized placebo-controlled dose-response study. Cephalalgia2002;22:523-32. ">Pfaffenrath 2002</a>, follow the IHS guidelines for controlled trials of drugs in migraine prevention (<a href="./references#CD002286-bbs2-0049" title="Tfelt-HansenP , PascualJ , RamadanN , DahlöfC , D'AmicoD , DienerHC , et al, International Headache Society Clinical Trials Subcommittee. Guidelines for controlled trials of drugs in migraine: third edition. A guide for investigators. Cephalalgia2012;32:6-38.">Tfelt‐Hansen 2012</a>). </p> </section> <section id="CD002286-sec-0058"> <h3 class="title" id="CD002286-sec-0058">Potential biases in the review process</h3> <p>By carrying out a thorough search for relevant studies and following Cochrane review methods we aimed to minimise the risk of bias in the review process itself. </p> <p>One trial is available as an abstract only (<a href="./references#CD002286-bbs2-0010" title="KarimooyHN , GholamnezhadZ , TalebiM . Effect of tanacetum parthenium (feverfew) in treatment of migraine headache comparing to dihydroergotamine and placebo. In: Pain Medicine. Vol. 12. 2011:487. ">Karimooy 2011</a>). It is a controlled clinical trial (n = 168) of feverfew for the treatment of migraine headache compared to dihydroergotamine and placebo. Relevant data about methods and results are missing in the abstract, which makes it impossible to assess the study. We contacted the authors who confirmed that the study has not been published in full but were unable to provide any further details of the trial. It therefore remains unclear whether the study assessed migraine prevention and was randomised. The use of dihydroergotamine suggests that treatment rather than prevention of migraine was investigated. We have therefore excluded the study and are confident that its results would not have changed the overall outcome of this review. </p> </section> <section id="CD002286-sec-0059"> <h3 class="title" id="CD002286-sec-0059">Agreements and disagreements with other studies or reviews</h3> <p>The findings from the randomised clinical trials have been reported in other reviews (<a href="./references#CD002286-bbs2-0041" title="PareekA , SutharM , RathoreGS , BansalV . Feverfew (Tanacetum parthenium) L.): a systematic review. Pharmacognosy Reviews2011;5:103-10.">Pareek 2011</a>; <a href="./references#CD002286-bbs2-0046" title="Sun-EdelsteinC , MauskopA . Foods and supplements in the management of migraine headaches. Clinical Journal of Pain2009;25:446-52.">Sun‐Edelstein 2009</a>). The most recent systematic review of feverfew for migraine, published in 2009, also includes six trials (<a href="./references#CD002286-bbs2-0044" title="SaranitzkyE , WhiteCM , BakerEL , BakerWL , ColemanCI . Feverfew for migraine prophylaxis: a systematic review. Journal of Dietary Supplements2009;6:91-103.">Saranitzky 2009</a>). The authors do not include the <a href="./references#CD002286-bbs2-0005" title="PalevitchD , EaronG , CarassoR . Feverfew (Tanacetum parthenium) as a prophylactic treatment for migraine: a double-blind placebo-controlled study. Phytotherapy Research1997;11:508-11. ">Palevitch 1997</a> study, which is published in a journal not indexed by MEDLINE, but include a RCT of a feverfew combination product (<a href="./references#CD002286-bbs2-0012" title="MaizelsM , BlumenfeldA , BurchetterR . A combination of riboflavin, magnesium, and feverfew for migraine prophylaxis: a randomized trial. Headache2004;44:885-90. ">Maizels 2004</a>), which we excluded from this Cochrane review as it does not allow any conclusions about the role of feverfew alone. The review concludes that "currently available research examining feverfew for migraine is promising especially with the dried feverfew leaf formulations. However, more research ... is needed before it can be recommended to a general population." (<a href="./references#CD002286-bbs2-0044" title="SaranitzkyE , WhiteCM , BakerEL , BakerWL , ColemanCI . Feverfew for migraine prophylaxis: a systematic review. Journal of Dietary Supplements2009;6:91-103.">Saranitzky 2009</a>). </p> </section> </section> </section> <div class="figures-list"> <div class="figure" id="CD002286-fig-0001"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD002286.pub3/media/CDSR/CD002286/urn:x-wiley:14651858:media:CD002286:CD002286-FIG-01" target="_blank"><b></b></a></p> </div><img alt="Study flow diagram." data-id="CD002286-fig-0001" src="/cdsr/doi/10.1002/14651858.CD002286.pub3/media/CDSR/CD002286/image_n/nCD002286-FIG-01.png"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD002286.pub3/media/CDSR/CD002286/image_t/tCD002286-FIG-01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 1</div> <div class="figure-caption"> <p>Study flow diagram.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD002286.pub3/full#CD002286-fig-0001">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD002286.pub3/media/CDSR/CD002286/image_n/nCD002286-FIG-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD002286-fig-0002"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD002286.pub3/media/CDSR/CD002286/urn:x-wiley:14651858:media:CD002286:CD002286-FIG-02" target="_blank"><b></b></a></p> </div><img alt="'Risk of bias' summary: review authors' judgements about each risk of bias item for each included study." data-id="CD002286-fig-0002" src="/cdsr/doi/10.1002/14651858.CD002286.pub3/media/CDSR/CD002286/image_n/nCD002286-FIG-02.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD002286.pub3/media/CDSR/CD002286/image_t/tCD002286-FIG-02.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 2</div> <div class="figure-caption"> <p>'Risk of bias' summary: review authors' judgements about each risk of bias item for each included study. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD002286.pub3/full#CD002286-fig-0002">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD002286.pub3/media/CDSR/CD002286/image_n/nCD002286-FIG-02.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD002286-fig-0003"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD002286.pub3/media/CDSR/CD002286/urn:x-wiley:14651858:media:CD002286:CD002286-FIG-03" target="_blank"><b></b></a></p> </div><img alt="'Risk of bias' graph: review authors' judgements about each risk of bias item presented as percentages across all included studies." data-id="CD002286-fig-0003" src="/cdsr/doi/10.1002/14651858.CD002286.pub3/media/CDSR/CD002286/image_n/nCD002286-FIG-03.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD002286.pub3/media/CDSR/CD002286/image_t/tCD002286-FIG-03.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 3</div> <div class="figure-caption"> <p>'Risk of bias' graph: review authors' judgements about each risk of bias item presented as percentages across all included studies. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD002286.pub3/full#CD002286-fig-0003">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD002286.pub3/media/CDSR/CD002286/image_n/nCD002286-FIG-03.svg" target="_blank">Open in new tab</a></div> </div> </div> <noscript> <img height="1" src="/scolaris-auth/report/nonjs/fulltexthtmlreg?doi=10.1002%2F14651858.CD002286.pub3&amp;rf=&amp;articleType=CDSR" style="display:none" width="1"> </img></noscript> <section class="translation-notes-modal" data-modal-class="translation-notes" data-modal-title="Translation notes" data-ok-btn-selector=".ok-btn" style="display: none"> <div class="translation-notes"> <div class="section-language-toggles"> <nav class="section-languages"> <ul> <li class="section-languages-legend">Available in</li> <li class="section-language"> <a class="" href="de#CD002286-note-0002">Deutsch</a> </li> <li class="section-language"> <a class="" href="es#CD002286-note-0012">Español</a> </li> <li class="section-language"> <a class="" href="fa#CD002286-note-0009">فارسی</a> </li> <li class="section-language"> <a class="" href="fr#CD002286-note-0010">Français</a> </li> <li class="section-language"> <a class="" href="hr#CD002286-note-0008">Hrvatski</a> </li> <li class="section-language"> <a class="" href="ja#CD002286-note-0007">日本語</a> </li> <li class="section-language"> <a class="" href="ko#CD002286-note-0005">한국어</a> </li> <li class="section-language"> <a class="" href="ms#CD002286-note-0006">Bahasa Malaysia</a> </li> <li class="section-language"> <a class="" href="pl#CD002286-note-0011">Polski</a> </li> <li class="section-language"> <a class="" href="ru#CD002286-note-0004">Русский</a> </li> <li class="section-language"> <a class="" href="zh_HANT#CD002286-note-0003">繁體中文</a> </li> </ul> </nav> </div> <section class="translation-notes-content"> </section> <button class="btn primary ok-btn pull-right" type="button">Close</button> </div> </section></article> </div> <div class="citation-modal" style="display: none"> <div class="export-citation-header"> <p class="inset-message" data-load-error="Unable to load citation data" id="citeProcText"></p> </div> <div class="export-citation-body row-fluid"> <div class="span12"> <div class="addthis_toolbox addthis_default_style addthis_16x16_style"> <nav class="inline-nav-list is-bordered"> <li> <h4 class="heading">Save citation to:</h4> </li> <li><a class="citation-btn-refworks at300b btn btn-link" href="#" id="refWorksCitationBtn"><span class="citation-icon refworks"></span>RefWorks</a></li> <li><a class="citation-btn-sciwheel at300b btn btn-link disabled" href="#" id="sciWheelCitationBtn" target="_blank"><span class="citation-icon sciwheel"></span>SciWheel</a></li> </nav> </div> </div> </div> <div class="row-fluid"> <div class="span12"> <div class="citation-format"> <h4>Copy or download citation</h4> <a href="/en/help/exporting-search-results" rel="noopener noreferrer" target="_blank">Export help</a> </div> <nav class="inline-nav-list has-dividers"> <li class="citation-option" data-option="plain"><button class="btn btn-link" type="button">Plain text</button></li> <li class="citation-option" data-option="endnote"><button class="btn btn-link" type="button">EndNote</button></li> <li class="citation-option" data-option="refmanager"><button class="btn btn-link" type="button">Reference Manager</button></li> <li class="citation-option" data-option="procite"><button class="btn btn-link" type="button">ProCite</button></li> <li class="citation-option" data-option="bibtex"><button class="btn btn-link" type="button">BibteX</button></li> <li class="citation-option" data-option="csv"><button class="btn btn-link" type="button">CSV (Excel)</button></li> </nav> <div class="citation-content"> <pre data-load-error="Unable to load citation data" id="citationContent" tabindex="0"></pre> </div> <div class="clearfix"> <form class="download-citation-form" data-citation-citeproc-url="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=citation-citeproc&amp;p_p_cacheability=cacheLevelPage&amp;p_p_col_id=column-1&amp;p_p_col_count=1" method="GET" target="citation-download-iframe"> <input id="siteId" name="siteId" type="hidden" value=""> <input id="downloadType" name="downloadType" type="hidden" value=""> <input id="style" name="style" type="hidden" value=""> <input id="articleId" name="articleId" type="hidden" value=""> <input name="p_p_id" type="hidden" value="scolariscontentdisplay_WAR_scolariscontentdisplay"><input name="p_p_lifecycle" type="hidden" value="2"><input name="p_p_state" type="hidden" value="normal"><input name="p_p_mode" type="hidden" value="view"/><input name="p_p_resource_id" type="hidden" value="citation-download"/><input name="p_p_cacheability" type="hidden" value="cacheLevelPage"/><input name="p_p_col_id" type="hidden" value="column-1"/><input name="p_p_col_count" type="hidden" value="1"/> <button class="btn primary wide pull-right" type="submit">Download</button> <div class="inline-checkbox pull-right"> <label title=" for=" withabstract"=""> <input checked="" class="checkbox" name="withAbstract" type="checkbox"/> <span class="checkbox-label">Include abstract</span> </label> </div> </input></input></input></input></input></input></input></form> <iframe aria-hidden="true" name="citation-download-iframe" src="" style="display: none; visibility: hidden" title="Citation download frame"></iframe> </div> </div> </div> </div> <div class="print-modal" data-modal-title="Print this review" style="display: none;"> <div class="print-options-wrapper"> <p><strong>All sections are selected by default</strong>, please select the sections you do not wish to print or use the select or deselect all button to add or remove sections.</p> <div class="print-options-controls"> <input checked="checked" class="print-options-select-all" title="Select/deselect all" type="checkbox"/> <span class="checkbox-label">Select/deselect all</span> </div> <ul class="print-options checkbox-list"> </ul> <button class="btn primary print-article pull-right"><i aria-hidden="true" class="fa fa-print"></i> Print</button> </div> </div> <div class="download-stats-data-modal" data-modal-title="Download data package" style="display: none;"> <div> <p> The data available are protected by copyright and may only be used in accordance with the <a class="external" href="/about/data-download" target="_blank">Terms and Conditions.</a> </p> <div class="hide-for-zip"> <p> <a class="external" href="https://revman.cochrane.org/#/rm5Converter" target="_blank">RevMan 5 files</a> can be converted to a <a class="external" href="https://links.cochrane.org/review-datapack-userguide" target="_blank">data package.</a> </p> </div> <p> Files in the data package can be imported to <a class="external" href="https://revman.cochrane.org/info" target="_blank">Review Manager software</a> or opened in other tools that support CSV and RIS. </p> <form class="download-stats-data-form" method="GET" target="_blank"> <input name="content-disposition" type="hidden" value="attachment"/> <input name="mime-type" type="hidden" value="application/octet-stream"/> <p class="print-options-controls"> <input aria-label="I agree to these terms and conditions" class="download-stats-data-toc-check-box" type="checkbox"/> <span aria-hidden="true" class="checkbox-label">I agree to these terms and conditions</span> <button class="btn primary download-stats-data pull-right" disabled=""><i aria-hidden="true" class="fa fa-download"></i> Download data</button> </p> </form> </div> </div> <div class="share-modal" data-modal-title="Share this review" style="display:none;"> </div> <div class="viewer-thumbnail-pane-html" style="display:none;"> <div class="figure-viewer-options"> <nav class="inline-nav-list"> <li class="figure-options-btn-container"><button class="btn btn-link" id="figureOptionBtn" type="button">Figures</button></li> <li class="table-options-btn-container"><button class="btn btn-link" id="tableOptionBtn" type="button">Tables</button></li> </nav> </div> <div class="figure-viewer-thumbnails"> <div class="figure-thumbnails is-visible" id="figureThumbnails"></div> <div class="table-thumbnails" id="tableThumbnails"></div> </div> </div> <div class="utilities-html" style="display:none;"> <div class="figure-viewer-utilities"> <a class="figure-viewer-menu-toggle" href="#"> <i class="fa fa-chevron-left"></i><span class="toggle-label" data-figure-hide-text="Hide thumbnails" data-figure-show-text="Show thumbnails" data-table-hide-text="Hide table list" data-table-show-text="Show table list">Hide thumbnails</span> </a> <a class="figure-viewer-navigateback" href="#"> <i class="fa fa-chevron-left"></i> </a> <a class="figure-viewer-rotate" href="#"> <i class="fa fa-undo"></i> </a> <a class="figure-viewer-download" href="#"> <i class="fa fa-download"></i> </a> <a class="figure-viewer-share" href="#"> <i class="fa fa-share-alt"></i> </a> <a class="figure-viewer-zoomin" href="#"> <i class="fa fa-plus"></i><span>zoom in</span> </a> <a class="figure-viewer-zoomout" href="#"> <i class="fa fa-minus"></i><span>zoom out</span> </a> </div> </div> <div class="controls-html" style="display:none;"> <div class="figure-viewer-navigation"> <a class="figure-viewer-nav previous" href="#"> <i class="fa fa-chevron-left"></i><span>left</span> </a> <a class="figure-viewer-nav next" href="#"> <i class="fa fa-chevron-right"></i><span>right</span> </a> </div> </div> <div class="mobile-thumbnail-selector-html" style="display:none;"> <div class="figure-viewer-mobile-thumbnails"> <select class="figure-selection"> <option>Figures</option> </select> <select class="table-selection"> <option>Tables</option> </select> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div>
<div class="portlet-boundary portlet-boundary_1_WAR_kaleodesignerportlet_ portlet-static portlet-static-end kaleo-designer-portlet" id="p_p_id_1_WAR_kaleodesignerportlet_">
<span id="p_1_WAR_kaleodesignerportlet"></span>
</div>
<form action="#" id="hrefFm" method="post" name="hrefFm">
<span></span>
</form>
</div>
<footer class="footer">
<div class="main-footer">
<div class="main-footer-wrapper container">
<div class="brand">
<p class="brand-name">Cochrane</p>
<a href="http://www.cochrane.org/" title="Cochrane logo">
<img alt="Cochrane logo" class="footer-logo logo-part-1" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-1.png"> <img alt="" class="footer-logo logo-part-2" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-2.png"> </img></img></a> </div> </div> </div> <div class="aux-footer"> <div class="aux-footer-nav-container container"> <nav class="aux-footer-nav"> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse Publications</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse by Subject</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/advertisers">Advertisers &amp; Agents</a></li> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Contact Us</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Help &amp; Support</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/terms-and-conditions">Terms &amp; Conditions</a></li> </ul> </nav> </div> <div class="brand"> <div class="brand-container container"> <p class="copyright"> Copyright © 2000 - 2025 by <a class="" href="http://www.wiley.com">John Wiley &amp; Sons, Inc.</a> All Rights Reserved <br/> Review our <a href="https://www.wiley.com/privacy"><strong>Privacy Policy</strong></a> <a href="https://www.wiley.com/cookies"><strong>Cookie Policy</strong></a> <a href="#" onclick="Osano.cm.showDrawer('osano-cm-dom-info-dialog-open')"><strong>Cookie Preferences</strong></a> </p> <a href="http://eu.wiley.com/"><img alt="Wiley logo" class="logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_wiley-footer-logo.png"/></a> </div> </div> <span class="wiley-semi-circle"></span> </div> <!--BEGIN QUALTRICS WEBSITE FEEDBACK SNIPPET--> <script type="text/javascript"> (function(){var g=function(e,h,f,g){ this.get=function(a){for(var a=a+"=",c=document.cookie.split(";"),b=0,e=c.length;b<e;b++){for(var d=c[b];" "==d.charAt(0);)d=d.substring(1,d.length);if(0==d.indexOf(a))return d.substring(a.length,d.length)}return null}; this.set=function(a,c){var b="",b=new Date;b.setTime(b.getTime()+6048E5);b="; expires="+b.toGMTString();document.cookie=a+"="+c+b+"; path=/; "}; this.check=function(){var a=this.get(f);if(a)a=a.split(":");else if(100!=e)"v"==h&&(e=Math.random()>=e/100?0:100),a=[h,e,0],this.set(f,a.join(":"));else return!0;var c=a[1];if(100==c)return!0;switch(a[0]){case "v":return!1;case "r":return c=a[2]%Math.floor(100/c),a[2]++,this.set(f,a.join(":")),!c}return!0}; this.go=function(){if(this.check()){var a=document.createElement("script");a.type="text/javascript";a.src=g;document.body&&document.body.appendChild(a)}}; this.start=function(){var t=this;"complete"!==document.readyState?window.addEventListener?window.addEventListener("load",function(){t.go()},!1):window.attachEvent&&window.attachEvent("onload",function(){t.go()}):t.go()};}; try{(new g(100,"r","QSI_S_ZN_cGCHHvWNpnJb1zf","https://zncgchhvwnpnjb1zf-wiley.siteintercept.qualtrics.com/SIE/?Q_ZID=ZN_cGCHHvWNpnJb1zf")).start()}catch(i){}})(); </script><div id="ZN_cGCHHvWNpnJb1zf"><!--DO NOT REMOVE-CONTENTS PLACED HERE--></div> <!--END WEBSITE FEEDBACK SNIPPET--> </footer> <div class="scolaris-modal-overlay"></div> <div class="scolaris-modal"> <div class="scolaris-modal-titlebar clearfix"> <p class="scolaris-modal-title"></p> <a class="scolaris-modal-close" href="#"><span>close</span><span class="icon fa fa-times"></span></a> <div class="scolaris-modal-ui"></div> </div> <!-- Static injection of addtoAny as dynamic injection not working properly--> <div class="scolaris-share-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"> <div class="a2a_kit a2a_kit_size_32 a2a_default_style"> <a class="a2a_button_facebook share-button">  Facebook</a> <a class="a2a_button_x share-button">  X(Twitter)</a> <a class="a2a_button_whatsapp share-button">  WhatsApp</a> <a class="a2a_dd share-button">  View more</a> </div> </div> </div> <div class="scolaris-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="english-only-modal-wrapper" data-modal-class="english-only-modal" data-modal-title="Feature in English only" style="display: none"> <div class="english-only-modal"> <p class="message"></p> <button class="btn primary ok-btn pull-right" type="button">OK</button> <button class="btn primary border-only cancel-btn pull-right" type="button">Cancel</button> </div> </div> <!--[if gte IE 9]><!--> <script src="/cochrane-theme/vendor/ie9.js?t=1738734064000" type="text/javascript"></script> <!--<![endif]--> <script src="https://www.cochranelibrary.com/cochrane-theme/js/theme.js?t=1738734064000" type="text/javascript"></script> <script src="https://content.readcube.com/cochrane/checkout.js"></script> <script src="https://content.readcube.com/cochrane/epdf_linker.js" type="text/javascript"></script> <script src="https://crossmark-cdn.crossref.org/widget/v2.0/widget.js" type="text/javascript"></script> <script src="https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/hit-highlighting.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/topics-lookup.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/institution.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/api-manager.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/pico.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/reference-linking.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/rightsLink.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.submit.failed.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.comment.form.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/safety-alerts.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.translation-notes-modal.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/notifications-portlet/notifications/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772751000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-search/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772894000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-topics/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772894000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-language-portlet/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772746000" type="text/javascript"></script> <script type="text/javascript">Liferay.Util.addInputFocus();</script> <script type="text/javascript">Liferay.Portlet.register("scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_",portletId:"scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD002286\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD002286\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD002286\x2epub3\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD002286\x2epub3"});Liferay.Portlet.register("scolariscontentdisplay_WAR_scolariscontentdisplay");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_",portletId:"scolariscontentdisplay_WAR_scolariscontentdisplay",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentdisplay_WAR_scolariscontentdisplay\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dcolumn-1\x26p_p_col_pos\x3d0\x26p_p_col_count\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD002286\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD002286\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D"});Liferay.provide(Liferay.Util,"openKaleoDesignerPortlet",function(c){var b=AUI();var e=Liferay.PortletURL.createURL("https://www.cochranelibrary.com/en/content?p_p_id=2_WAR_kaleodesignerportlet&p_p_lifecycle=0");e.setParameter("mvcPath","/designer/edit_kaleo_draft_definition.jsp");e.setParameter("availableFields",c.availableFields);e.setParameter("availablePropertyModels",c.availablePropertyModels);e.setParameter("ddmStructureId",c.ddmStructureId);e.setParameter("draftVersion",c.draftVersion);e.setParameter("kaleoProcessId",c.kaleoProcessId);e.setParameter("name",c.name);e.setParameter("openerWindowName",c.openerWindowName);e.setParameter("portletResourceNamespace",c.portletResourceNamespace);e.setParameter("propertiesSaveCallback",c.propertiesSaveCallback);e.setParameter("refreshOpenerOnClose",c.refreshOpenerOnClose);e.setParameter("saveCallback",c.saveCallback);e.setParameter("version",c.version);e.setWindowState("pop_up");c.uri=e.toString();var d=c.dialog;if(!d){var f=b.one(Liferay.Util.getOpener()).get("region");d={destroyOnHide:true};c.dialog=d}if(!("align" in d)){d.align=Liferay.Util.Window.ALIGN_CENTER}var a=c.dialogIframe;if(!a){a={closeOnEscape:false};c.dialogIframe=a}Liferay.Util.openWindow(c)},["liferay-portlet-url"]);Liferay.Portlet.register("1_WAR_kaleodesignerportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_1_WAR_kaleodesignerportlet_",portletId:"1_WAR_kaleodesignerportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3d1_WAR_kaleodesignerportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD002286\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD002286\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD002286\x2epub3\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD002286\x2epub3"});Liferay.Portlet.register("scolarissearchportlet_WAR_scolarissearch");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarissearchportlet_WAR_scolarissearch_",portletId:"scolarissearchportlet_WAR_scolarissearch",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarissearchportlet_WAR_scolarissearch\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD002286\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD002286\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD002286\x2epub3\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD002286\x2epub3"});Liferay.Portlet.register("scolariscontentlanguagebanner_WAR_scolarislanguageportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_",portletId:"scolariscontentlanguagebanner_WAR_scolarislanguageportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentlanguagebanner_WAR_scolarislanguageportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD002286\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD002286\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD002286\x2epub3\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD002286\x2epub3"});AUI().use("aui-base","liferay-menu","liferay-notice","liferay-poller","liferay-session",function(a){(function(){Liferay.Util.addInputType();Liferay.Portlet.ready(function(b,c){Liferay.Util.addInputType(c)});if(a.UA.mobile){Liferay.Util.addInputCancel()}})();(function(){new Liferay.Menu();var b=Liferay.Data.notices;for(var c=1;c<b.length;c++){new Liferay.Notice(b[c])}})();(function(){Liferay.Session=new Liferay.SessionBase({autoExtend:true,sessionLength:1800,redirectOnExpire:false,redirectUrl:"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane",warningLength:0})})()});</script> <script src="https://www.cochranelibrary.com/cochrane-theme/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" type="text/javascript"></script> <script type="text/javascript"></script> <div class="mobile-righthand-nav"> <a class="rh-nav-close-btn" href="#"> <span>Close</span> <span class="fa fa-chevron-down"></span> </a> <div class="wrapper"> </div> <a class="rh-nav-open-btn" href="#"> <span>Review tools &amp; navigation</span> </a> </div> <iframe aria-hidden="true" id="printframe" name="printframe" style="position: absolute; left: -2000px; top: 0;" title="Print frame"></iframe> <iframe aria-hidden="true" id="citationExportFrame" name="citationExportFrame" style="position: absolute; left: -2000px; top: 0;" title="scolaris.citation.export.frame"></iframe> <nav> <div class="mobile-navigation"> <div class="close-container"> <a aria-label="Navigate back" class="main-nav-back-btn" href="#"><i class="fa fa-chevron-left"></i></a> <a class="main-nav-close-btn" href="#" title="Close menu">Close menu <i class="fa fa-times"></i></a> </div> <div class="mobile-search basic-search-container"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="ymag__null__null" src="/scolaris-search/icon.png"> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </img></span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=FKeXZrqu&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"> <input name="facetDisplayName" type="hidden" value=""> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</input></input></form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD002286.pub3&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD002286.pub3';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<a class="btn secondary" href="/en/browse-by-topic">Browse </a>
<a class="btn secondary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
<div class="menu-items parent">
<div>
<div class="nav-root-item parent">
<a class="language-selection-title-link" href="#" title="Select language">
<span class="mobile-nav-language-title">Select your preferred language </span></a> <span class="icon fa fa-caret-down"></span>
<div class="mob-child">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="fdkn__null__null" src="/scolaris-language-portlet/icon.png"> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </img></span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> English </a> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> English </a> </div> <div class="form-content language-selector-modal child"> <div class="row-fluid"> <h3><i class="fa fa-file-text"></i> Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> <div class="dropdown-trigger" id="active-content-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="content-language-selector" data-languagecode="de" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=de">Deutsch</a> <a class="content-language-selector is-active" data-languagecode="en" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=en">English</a> <a class="content-language-selector" data-languagecode="es" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=es">Español</a> <a class="content-language-selector" data-languagecode="fa" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fa">فارسی</a> <a class="content-language-selector" data-languagecode="fr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fr">Français</a> <a class="content-language-selector" data-languagecode="hi" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hi">हिन्दी</a> <a class="content-language-selector" data-languagecode="hr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hr">Hrvatski</a> <a class="content-language-selector" data-languagecode="id" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=id">Bahasa Indonesia</a> <a class="content-language-selector" data-languagecode="ja" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ja">日本語</a> <a class="content-language-selector" data-languagecode="ko" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ko">한국어</a> <a class="content-language-selector" data-languagecode="hu" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hu">Magyar</a> <a class="content-language-selector" data-languagecode="ms" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ms">Bahasa Malaysia</a> <a class="content-language-selector" data-languagecode="nl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=nl">Nederlands</a> <a class="content-language-selector" data-languagecode="pl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pl">Polski</a> <a class="content-language-selector" data-languagecode="pt" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pt">Português</a> <a class="content-language-selector" data-languagecode="ru" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ru">Русский</a> <a class="content-language-selector" data-languagecode="ro" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ro">Română</a> <a class="content-language-selector" data-languagecode="ta" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ta">தமிழ்</a> <a class="content-language-selector" data-languagecode="th" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=th">ภาษาไทย</a> <a class="content-language-selector" data-languagecode="zh_HANT" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANT">繁體中文</a> <a class="content-language-selector" data-languagecode="zh_HANS" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANS">简体中文</a> </div> </div> <div class="row-fluid"> <h3 class="portal-language-header"><i class="fa fa-globe"></i> Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> <div class="dropdown-trigger" id="active-portal-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="portal-language-selector is-active" data-portallanguage="en" href="/en/cdsr/doi/10.1002/14651858.CD002286.pub3/full/en">English</a> <a class="portal-language-selector" data-portallanguage="es" href="/es/cdsr/doi/10.1002/14651858.CD002286.pub3/full/es">Español</a> </div> </div> <a class="btn secondary ok-btn pull-right" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
<div class="parent">
<a class="mobile-link signin" data-redirect="false" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD002286.pub3%2Ffull" rel="nofollow">
                        Sign In
                    </a>
</div>
</div>
<div class="menu-items-footer">
<div class="utility-links">
<a class="cochrane-link" href="http://www.cochrane.org/" target="_blank">Visit Cochrane.org</a>
</div>
</div>
</div>
<div class="menu-items child"></div>
</div>
</nav><div class="basic-login-form-content" data-modal-title="Sign in" style="display: none;">
<div class="form-content">
<div class="row-fluid">
<div class="span12">
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_MODAL_">
<span id="p_58_INSTANCE_MODAL"></span>
<section class="portlet" id="portlet_58_INSTANCE_MODAL">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="dbam__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"/> <span class="taglib-text hide-accessible">Sign In</span> </span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_MODAL" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_MODAL&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_MODAL_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_MODAL_fm" method="post" name="_58_INSTANCE_MODAL_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_MODAL_formDate" type="hidden" value="1740727143517"> <input class="field" id="_58_INSTANCE_MODAL_saveLastPath" name="_58_INSTANCE_MODAL_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_MODAL_redirect" name="_58_INSTANCE_MODAL_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD002286.pub3/full"> <input class="field" id="_58_INSTANCE_MODAL_doActionAfterLogin" name="_58_INSTANCE_MODAL_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_login"> Email Address </label> <input class="field clearable" id="_58_INSTANCE_MODAL_login" name="_58_INSTANCE_MODAL_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_password"> Password </label> <input class="field" id="_58_INSTANCE_MODAL_password" name="_58_INSTANCE_MODAL_password" type="password" value=""/> </div> <span id="_58_INSTANCE_MODAL_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="clearfix"> <div class="checkbox-list pull-left"> <div class="checkbox-list-item"> <div class="control-group form-inline input-checkbox-wrapper"> <label for="_58_INSTANCE_MODAL_rememberMeCheckbox"> <input id="_58_INSTANCE_MODAL_rememberMe" name="_58_INSTANCE_MODAL_rememberMe" type="hidden" value="true"/> <input checked="" class="field" id="_58_INSTANCE_MODAL_rememberMeCheckbox" name="_58_INSTANCE_MODAL_rememberMeCheckbox" onclick="Liferay.Util.updateCheckboxValue(this); " type="checkbox" value="true"/> Remember Me </label> </div> </div> </div> <div class="pull-right"> <a href="https://onlinelibrary.wiley.com/user/forgottenpassword" target="_blank">Forgotten password?</a> </div> </div> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> <a class="btn secondary" href="https://onlinelibrary.wiley.com/user-registration" target="_blank">Register</a> </div> <div class="pull-right"> <a class="institutional-login-form-button" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=0&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolariscontentdisplay_WAR_scolariscontentdisplay_action=institution-access">Institutional login</a> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div></div>
<div class="institution-login-form-content" data-modal-title="Institutional login" style="display: none;">
<div class="form-content">
<div class="row-fluid access-content-wrapper">
<div class="span12">
<div class="section">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="obft__null__null" src="/scolaris-content-display/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="access-content-section"> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/>
</div>
<button class="btn primary" name="button" type="submit">Go</button>
</div>
<div class="message error" id="institutionLookupErrorDiv" style="display:none">
                        '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access.
                    </div>
</div>
<input id="entityId" name="entityId" type="hidden" value=""/>
</form>
<h4>Previously accessed institutions</h4>
<ul class="plain" id="previousInstitutions">
<li>(none)</li>
</ul>
</div>
<div class="section-content">
<div class="open-athens-login">
                Login using <a href="/openathens">OpenAthens</a>
</div>
</div>
</div>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_4_">
<span id="p_58_INSTANCE_4"></span>
<section class="portlet" id="portlet_58_INSTANCE_4">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="joiu__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"/> <span class="taglib-text hide-accessible">Sign In</span> </span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_4" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <p>If you have a <strong>Wiley Online Library</strong> institutional username and password, enter them here.</p> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_4&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_4_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_4_fm" method="post" name="_58_INSTANCE_4_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_4_formDate" type="hidden" value="1740727143521"> <input class="field" id="_58_INSTANCE_4_saveLastPath" name="_58_INSTANCE_4_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_4_redirect" name="_58_INSTANCE_4_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD002286.pub3/full"> <input class="field" id="_58_INSTANCE_4_doActionAfterLogin" name="_58_INSTANCE_4_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_login"> Username </label> <input class="field clearable" id="_58_INSTANCE_4_login" name="_58_INSTANCE_4_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_password"> Password </label> <input class="field" id="_58_INSTANCE_4_password" name="_58_INSTANCE_4_password" type="password" value=""> </input></div> <input class="field" id="_58_INSTANCE_4_institutionalLogin" name="_58_INSTANCE_4_institutionalLogin" type="hidden" value="true"/> <span id="_58_INSTANCE_4_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div></div>
<div class="get-access-form-content" data-modal-title="Unlock gold-standard Cochrane evidence" style="display: none;">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="wpdq__null__null" src="/scolaris-content-display/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="readcube-checkout-container-outer"> <div class="row-fluid access-content-wrapper"> <div class="span6 access-left-content"> <div class="section"> <div class="section-content"> <p>Improve your health decisions with access to trusted, independent evidence from the Cochrane Library. Unlock this review for uninterrupted access.</p> <p>Still deciding? <a href="https://m.info.wiley.com/webApp/cochranenewsletter"> Sign up to our newsletter to learn more </a> </p> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title">Institutional users</h3> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/> </div> <button class="btn primary" name="button" type="submit">Go</button> </div> <div class="message error" id="institutionLookupErrorDiv" style="display:none"> '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access. </div> </div> <input id="entityId" name="entityId" type="hidden" value=""/> </form> <h4>Previously accessed institutions</h4> <ul class="plain" id="previousInstitutions"> <li>(none)</li> </ul> </div> <div class="section-content"> <div class="open-athens-login"> Login using <a href="/openathens">OpenAthens</a> </div> </div> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title"> Other access options </h3> <div class="section-content"> <ul class="plain"> <li> <a class="get-access-individual-login-button" href="/c/portal/login"> Individual access - via Wiley Online Library </a> </li> </ul> </div> </div> </div> </div> <div class="span6 access-right-content readcube-checkout-container"> <div class="section"> </div> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/> <input id="openlabel" name="openlabel" type="hidden" value="Open access"/> </div> </section> </div> </div> <!-- Scolaris Version: --> <script type="text/javascript">if(window._satellite){_satellite.pageBottom()};</script> </div> <script>(function(){function c(){var b=a.contentDocument||a.contentWindow.document;if(b){var d=b.createElement('script');d.innerHTML="window.__CF$cv$params={r:'918ea4e16f8b9365',t:'MTc0MDcyNzE0NC4wMDAwMDA='};var a=document.createElement('script');a.nonce='';a.src='/cdn-cgi/challenge-platform/scripts/jsd/main.js';document.getElementsByTagName('head')[0].appendChild(a);";b.getElementsByTagName('head')[0].appendChild(d)}}if(document.body){var a=document.createElement('iframe');a.height=1;a.width=1;a.style.position='absolute';a.style.top=0;a.style.left=0;a.style.border='none';a.style.visibility='hidden';document.body.appendChild(a);if('loading'!==document.readyState)c();else if(window.addEventListener)document.addEventListener('DOMContentLoaded',c);else{var e=document.onreadystatechange||function(){};document.onreadystatechange=function(b){e(b);'loading'!==document.readyState&&(document.onreadystatechange=e,c())}}}})();</script></body> </html> 